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This work provides a comprehensive assessment of surgical implant and tissue 
interface stability. The implants have been evaluated under different conditions 
within distinct tissues including cartilage and bone. The first chapter, literature 
review, offers a broad discussion of current challenges associated with implant 
placement in tissues as well as novel techniques that have been found to improve 
the stability of the implant and have a positive influence on the long-term 
integration.  
Placing an implant in tissue leads to injury which must heal over time and healing 
results in the long-term integration of the implant. Several techniques have been 
described to improve the integration process, which essentially improves the 
healing of injured tissue. Some of these techniques concern novel implant designs 
which increase tissue and implant contact surface and therefore reduce focal 
stresses applied during insertion, distributing them over larger tissue area. Another 
common technique to improve long-term integration is coating the implants with 
various kinds of bioactive agents. Popular examples include growth factors and 
minerals which have been known to directly stimulate the healing process. 
The following two chapters relate to ex-vivo research conducted on several 
implants placed in cartilage and bone. Suture and thyroid cartilage interface 
stability was evaluated with a single pullout to failure test on the laryngeal 
advancement constructs. The conclusions of this study lead to improved implant 
design which showed higher primary stability than the existing suture. The 
succeeding study evaluated osseointegration of screw implants placed in a 
dynamic compression plate to stabilize tibial defect using the peak reverse torque 
(PRT) method. Self-tapping screws were found to have better osseointegration 
after 60 days of loading as compared to non-self-tapping screws. Another 
conclusion of this study revealed that peak reverse torque can be used to measure 
the axial stability of an orthopedic plate.  
Two final chapters relate to in-vivo studies and focus on the osseointegration of 
novel technology tissue scaffolding. Osseointegration of temporary bone fillers is 
an absolute prerequisite to enhance bone regeneration. Scaffolds were evaluated 
without additives in the goat and equine animal model as well as coated with 
recombinant human bone morphogenetic protein-2 and seeded with allogenic 









The stability of implant and tissue interface is vital for a long-term implant 
integration with adjacent tissue and directly impacts the surgical outcome. 
Literature provides comprehensive research conducted on implants engaged in 
soft as well as in hard tissues evaluating further their stability. The results helped 
establish several factors that have been found to be of importance in interface 
stability.  
This comprehensive work incorporated research projects with the main focus on 
implant and tissue interface stability, which were evaluated using biomechanical 
assessment tools such as pullout as well as reverse torque measurement tests. 
Implants were evaluated under ex-vivo conditions, immediately after placement 
within the tissue as well as under in-vivo conditions, 2- and 6-months following 
implantation surgery in the goat and equine animal model.  
In the following studies, the stability of interface has been found to be primarily 
influenced by several factors, including the amount of load experienced by the 
implants, stress applied by the implants to adjacent tissue as well as bioactive 
coatings. Furthermore, the studies included in this dissertation offer novel 
technologies that aim to improve interface stability-enhancing implant integration 
and tissue regeneration. These technologies concern novel design laryngeal 
clamps used to improve stability of laryngeal advancement constructs and novel 
technology polyurethane scaffolds coated with bioactive nanophase 
Hydroxyapatite to significantly enhance bone regeneration.  
The research incorporated in this work found that increased tissue and implant 
contact areas resulted in increased interface stability and better integration. 
Furthermore, incorporation of bioactive coatings in bone scaffolds significantly 
enhanced osseointegration ultimately resulting in improved tissue regeneration. 
Laryngeal clamps with higher cartilage to implant contact area were superior in 
biomechanical testing as compared with standard suture. Self-tapping screws with 
an increased bone to implant contact area revealed higher osseointegration after 
60 days of loading as compared with Non-self-tapping screws. Bioactive coatings 
such as nanophase Hydroxyapatite with decellularized bone particles or 
Mesenchymal Stem Cells were found to significantly enhance osseointegration of 
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Surgical implants are routinely used in soft tissue as well as in orthopedic surgery, 
with a very wide range of applications. Common examples include screws, plates, 
and suture anchors used in orthopedics as well as sutures used in soft tissue and 
scaffolds used in tissue regeneration. Integration between implant and tissue is 
vital for construct stability and directly influences short- and long-term surgical 
outcomes. Therefore, current research aims to continuously improve the 
integration process. Optimally, implants will not lead to adverse reactions 
associated with surgery as well as will stimulate the integration process. Every 
implant insertion leads to tissue injury, which heals over time resulting in following 
implant integration. The integration process is associated with a strengthening of 
the implant-tissue interface. Several factors have been found to negatively as well 
as positively influence this process in distinct tissues. This literature review 
provides a comprehensive look into current knowledge about implant and tissue 
interface and novel approaches to strengthen the interface. Last paragraphs 
review approaches for biomechanical testing used to evaluate the integration 
process. 
Surgical Implant and Cartilage Interface 
Implant integration within cartilage is challenging due to tissue avascular nature as 
well as dense and rich in proteoglycans extracellular matrix (EM), strong forces 
applied to joint surface during physiologic joint motion and low coefficient of friction 
(1,2). Implantation process causes an injury within the tissue which further results 
in death of adjacent chondrocytes (2). Because of pour vascularization, material 
which would facilitate regeneration process is not accessible. This includes 
chondrogenic progenitor cells from circulating blood and marrow as well as 
resident chondrocytes which cannot migrate through the dense EM. All those 
factors have been found to negatively affect the integration process.  
Anatomically, articular cartilage consists of chondrocytes that are surrounded by 
an extensive extracellular matrix which takes up to 90 % of tissue volume and 
contains primary water, aggrecans as well as type II collagen (1). Tissue is 
organized in four distinct areas which have been defined as the superficial zone, 
the intermediate zone, the radial zone and the calcified zone. All the anatomic 
structures have been involved in implant and tissue interface strengthening.  
Pour ability of cartilage to regenerate chondral lesions has been confirmed on the 
lesions bigger than 6 mm in diameter (3). The osteochondral lesions have a better 
healing prognosis since the injury extends to subchondral bone causing bleeding 
(1). Blood coming from bone provides growth factors, mesenchymal stem cells and 
platelets necessary for the regeneration process. The blood clot formed after 
osteochondral injury can fill the defects with diameter below 23 mm in their entirety 
(1). Tissue repair is a complicated process which results in a transient 




is mechanically inferior to hyaline cartilage due to higher collagen I to collagen II 
ratio as well as lower proteoglycan content (4). It may appear that defect is healed 
after replacing it with fibrocartilage, however due inferior mechanical properties, 
microcracking will occur around margins between regenerated tissue and hyaline 
cartilage which will ultimately lead to the full thickness fissures (5-7). Continuous 
transition on interface of the implant is vital for the integration process because it 
provides chondrocyte viability (1).   
Implant integration within cartilage is highly dependent on collagen fibers 
attachment to the surface of an implant as well as on chondrocyte migration and 
repopulation the interface. The implants placed in subchondral bone achieve 
higher stability than those placed only in cartilage which commonly result in a 
higher grade of integration (8). Furthermore, it was shown that the size, modulus, 
coefficient of friction, and poisons ratio of the implant is critically important in long-
term integration (8). The implants with a size of 5 mm lead to a very small tissue 
damage and result in successful fixation within surrounding tissue (8). Chondral as 
well as osteochondral implants with lower material modulus, and higher coefficient 
of friction caused more damage to the interface due to higher shear stresses 
related to joint motion. The increase in Poisson’s ratio was associated with a higher 
damage of surrounding tissue in implants placed in osteochondral defects as 
compared with the implants placed in chondral defects. The differences in 
coefficient of friction and poisson’s ratio between cartilage and the implant have 
been attributed to different organization in collagen fiber distribution as well as 
different collagen content and crosslink density (9).  
Implantation process has been associated with tissue injury which under in-vitro 
conditions resulted in a zone of cell death characterized by a band of necrosis 100-
200 microns wide. The necrosis was followed by a gradual cell apoptosis over 14 
days period and it extended the band up to 400 microns from the center of injury 
(10,11). Surviving cells outside the necrotic zone repopulate the matrix but they 
can only attach to the same lacunae as daughter cells and are not able to invade 
entire matrix (11). Because of the limitations in resident chondrocytes migration, 
delivering an implant with new chondrocytes can enhance the integration process 
(12-14). According to one study, autografts should contain between 5 and 30 
million chondrocytes depending on the size of the defect (14). The source of new 
cells, including animal species from which the graft was harvested as well as the 
origin of implanting graft (auricular cartilage, tracheal cartilage etc.) are in a critical 
importance (12,13). The presence of even a small number of senescent cells within 
a graft has been associated with a negative influence on regeneration due to the 
pro-inflammatory properties, catabolic phenotype as well as existence of 
metalloproteinases (15). Cell apoptosis can be inhibited using caspase inhibitors 
such as ZVAD-fmk, however the current results are not convincing (16).  
Collagen network has been also found to be important in creating implant and 




collagen fibers to the surface of an implant (1). It was found that fusion of distinct 
cartilages with different developmental stages may cause lysyl-oxidase mediated 
collagen crosslinking which negatively impacts integration (17). Modulation of this 
process before implantation using β–aminopropionitrile, stimulates collagen 
maturation and increases its adhesive strength (18). Disruption of collagen fibers 
either through injury or enzymatic digestion leads to 10 times accelerated cellular 
proliferation and increased chondrocyte mobility which further repopulate the 
interface enhancing integration and mechanical strength of an implant (19,20). The 
most common enzymatic approaches include treatment with collagenase, 
chondroitinase ABC, trypsin or hyaluronidase (19-27). Furthermore, enzymatic 
treatment improves proteoglycan synthesis for a longer duration (24). It was also 
found that chemotactic agents such as insulin like growth factor-1 (IGF-1) and 
recombinant human bone morphogenetic protein -2 (BMP-2) boosted cell 
migration (28,29). 
Several adhesives which improve implant stability have been described and the 
most commonly used from them is fibrin glue (30). Chemically modified chondroitin 
sulphate biopolymers with metacrylate and aldehyde groups to connect 
biomaterials and tissue protein have been also described (30). Collagen adhesion 
protein (CNA) is a bacterial surface protein synthetized by Staphylococcus areus 
to attach to monomeric chains of collagen (31,32). It is a well characterized protein 
with a high binding affinity to collagen type I and type II (31,32). Other examples 
of biologic adhesives include cationized gelatin (33) RGDs (34), multiple peptides 
in combination (such as RGD, YIGSR, and IKVAV) (35), and extracellular matrix 
proteins with or without growth factors such as collagen II and fibroblast growth 
factor (36). The molecules locally presented in synovial fluid which provides 
lubrication within the joint, included PRG4 (SZP/lubricin/megakaryocyte 
stimulating factor precursor) have been also associated with implant cartilage 
integration (37).  
Surgical Implant and Ligament Interface 
Similarly, like in cartilage, integration of an implant within ligament is challenging 
due to slow healing rate. This dense tissue is primarily composed of water (70%), 
collagen (25%) and matrix components which contain proteoglycans, fibronectin 
(4%) and tenocites (<1%) (38). Tissue structure is highly organized with tenocites 
as well as collagen fibers aligned longitudinally and interacting with one another 
through gap junctions, primarily connexin 32 and 43 (39). Slow healing has been 
attributed to limited vascular supply which is provided only in epiligament (38). 
Blood flow through the tissue is regulated by autonomic nerve supply and it may 
be increased during inflammation and tissue repair (40).  
Ligament healing leads to a scar formation, which is known to have inferior tensile 
strength and viscoelastic properties as compared with native ligament tissue 




with internal bleeding as well as blood clot formation (41). During this time, tissue 
debris resulted from injury is being removed and angiogenic cells together with 
fibroblasts are attracted to produce matrix consisting of fibrous connective tissue. 
Collagen ratio in a scar is changed and contains predominantly collagen type III, 
V, and VI with significantly lower amount of type I (41). During slow further 
regeneration (up to 2 years), number of cells and vessels decreases, and the 
collagen alignment improves as well as collagen ratio changes to predominantly 
collagen type I (41).  
Due to slow healing rate of injured tissue and significantly inferior mechanical 
properties, ligaments are not capable to resist physiologic tensile stresses and 
require immediate stabilization. Current regenerative research has targeted mostly 
collagen cross-links, predominant presence of type V collagen, and scar tissue 
formation (42-44). Level of collagen cross-links have been shown to decrease over 
1 year after injury what resulted in the inferior mechanical properties of scar tissue 
(42). Predominant presence of type V collagen has been further attributed to a 
smaller fiber diameter due to smaller size fibrils (43). The inferior properties of scar 
tissue have been associated with presence of non-tensile structures such as blood 
vessels, fat cells, disorganized collagen fibers and cellular infiltrates (mostly 
fibroblasts) (44).  
Regenerative research has found that cellular infiltrate within scar tissue are well 
responsive to growth factors, such as platelet derived growth factor (PDGF), basic 
fibroblastic growth factor (bFGF), epidermal growth factor (EGF) as well as 
transforming growth factor beta (TGF-beta) which stimulate their proliferation and 
collagen synthesis (44-46). Platelet rich plasma as a blood derived product, 
contains rich amount of majority of above-mentioned growth factors and therefore 
it has been shown to also stimulate the regenerative process (46). Further 
bioactive agents positively influencing ligament and tendon regeneration include 
hyaluronic acid (HA), collagen as well as mesenchymal stem cells (46).  
Besides the bioactive agents used to stimulate tissue regeneration, several 
implants have been utilized to provide immediate stabilization of injured tissue and 
common examples include sutures and allografts. Sutures are used to reattach the 
ends of a torn ligament to reduce gap between the fragments and increase contact 
surface. Allografts are used in ligaments containing a defect to also reduce gap 
and increase contact surface. Gap size and decreased contact surface have been 
associated with a higher amount of scar formation which has a negative influence 
on strength of healed ligament up to 2 years after the injury (47).  
Suturing process generates direct tissue trauma and cell death in tendons (48). 
Necrosis creates acellular zone in adjacent tissue within 72 hours which may 
persist for up to 1 year (48). This phenomenon was explained with tension applied 
across the suture grasp (49). Healing was not observed in the acellular zone for 




and aligned tendon cells (49,50). Acellular zone however led to an extended 
inflammation which has been found to result in adhesion formation (50). It has not 
been defined whether a predisposed location exist within ligament or tendon for 
this process to occur (50).  
Suture and ligament or suture and tendon interface have been found to be the 
weakest link in initial surgical repair due to lack of implant stability and cyclic motion 
(46,50). Studies, which have tested suture and ligament interface, have found that 
braided suture was significantly more abrasive than monofilament and caused a 
sawing effect during cyclical loading (51). This effect ultimately led to suture pulling 
through the soft tissue and failure of the construct (51). This could be resolved, 
increasing contact surface between the implant and tissue applying for example 
more complicated suture knots. They appeared to be more stable as compared 
with the simple knots, in a study which looked at differences between massive cut 
(MAC) and modified Mason-Allen (MMA) sutures in rotator cuff repair (52).  
Recent research has also introduced bio scaffold, porcine small intestine 
submucosa (SIS), which had promising results in tissue healing (46). Further 
proposed scaffold materials which had a positive influence on regeneration include 
biodegradable metallic scaffolds, porous magnesium or magnesium oxide (46). 
The aim of bio implants as well as bioactive agents is to enhance implant stability 
within tissue which would ultimately enhance the healing.  
Cartilage - and Soft Tissue - Bone Interface 
Bone, cartilage and ligament are often found in such anatomic structures as 
subchondral bone or ligament attachments. However, the relationship between 
tissues is not only anatomical but also physiological. Cooperation between them 
leads to a coordinated motion of the musculoskeletal system. Interaction between 
their interfaces can be further explained by transmission of mechanical forces. 
Cartilage is mostly suspected to compressive as well as shear stresses during joint 
kinematics, which are absorbed by the tissue and further transmitted to trabecular 
bone. Ligaments and tendons are mostly suspected to tension stresses during 
physiologic joint motion and muscle contraction which is further absorbed by the 
tissue and transmitted to bone. 
The communication and similarities between cartilage and bone have been already 
seen at the genetic level (54). Under in vitro conditions, osteoblasts are known to 
stimulate chondrocytes differentiation (55). Furthermore, in patients with 
osteoarthritis (OA) certain genes expressed by the osteoblasts harvested from 
sclerotic areas of subchondral bone have been found to modulate functions of 
chondrocytes (56). The genetic similarities between osteoblasts and chondrocytes 
can be explained with a similar developmental pathway merged with a common 
progenitor cell and confirm the communication theory between both tissues and 




As stated in paragraph above cartilage is defined as an avascular tissue which 
receives nutrients and oxygen through synovial fluid and from vasculature present 
in subchondral bone and calcified cartilage (54,57). Density of vasculature in 
subchondral bone has been directly influenced by the loading conditions (58). 
Further increase in vasculature density, protease expression, matrix degradation 
and increase in bone deposition adjacent to vasculature have been observed in 
bone with severe OA (59). Efficient transport across calcified cartilage from 
subchondral bone was proven in a study which measured concentration of 
hepatocyte growth factor within cartilage (60). In addition to vasculature, sensory 
nerves have been observed in the vascular channels at osteochondral junction 
which have been further associated with osteoarthritic pain in patients with OA 
(59).   
Ligament and bone interface is highly organized in a specific structure named 
enthesis (61). Entheses connect tissues with different biomechanical profiles and 
are therefore suspected to complex stresses (62). These include tensile stresses 
applied to ligament and compressive stresses applied to bone (61). The complex 
stresses within structures require from entheses to have a gradient in tissue 
organization in order to effectively transmit forces across the interface and 
maintain communication between cells with different phenotype (61). Gradient in 
tissue organization relates to four transition zones, including ligament, non-
mineralized fibrocartilage, mineralized fibrocartilage, and bone (61).  
Differences between all four zones have been explained with the stress distribution 
within enthesis. Tensile stresses are highest within ligament and gradually 
decrease towards bone (63). Gradual increase in mineralization across the 
interface is constant with gradual decrease in collagen fiber organization moving 
from ligament to bone and results in a smooth mechanical stress distribution 
(64,65). Furthermore, presence of hyaline cartilage between calcified tissue and 
bone is associated with tissue adjustment to compression stress.  In general, the 
differences are associated with ECM content, predominant collagen type (I,II,III 
and X) as well as cellular material (tenocytes, fibroblasts, fibrochondrocytes, 
osteoblasts, osteoclast and osteocytes) (61).  
Research in regenerative medicine and orthopedic surgery currently aims at 
designing devices which could be used to surgically repair and reattach injured 
soft tissue to bone, mimicking the sophisticated and complicated structure of 
enthesis. Up to date however, such devices which would ideally mimic the enthesis 
have not been designed yet and the surgical repair of enthesis results in a 
mechanically inferior fibrovascular tissue formation at the repair site (66). Suture 
anchors are currently the most commonly used surgical implants to reattach the 
ligaments. The implants consist of two parts connected through an eyelet, the 
anchor part which is buried in bone and the suture part which reattaches ligament. 
The biomedical engineering has utilized a combination of micro- and nano-




materials have been employed in the research including ceramics, natural 
polymers (alginate, silk, collagen) and synthetic polymers [poly(ɛ-caprolactone) 
(PCL), poly-L-lactic acid (PLLA), polyglycolic acid (PGA), and polylactid-co-
glycolid acid (PLGA)] (61). Similarly, on the ligament site, utilized materials include 
natural (collagen, silk) and synthetic polymers [polyglycolic acid (PGA), poly-L-
lactic acid (PLLA)] as well as decellularized native tendon or ligament (61).  
The target is to create hybrid materials with different mechanical properties to 
optimally mimic gradient in enthesis mechanical properties (61). Specifically, using 
a combination of polymer and ceramic with different Young’s modulus would better 
mimic the gradual mineralization across enthesis (67). An example includes a 
recent research done on complex and stratified collagen scaffold which 
incorporated following materials, collagen, collagen cross-linked with chondroitin 
sulfate and collagen mixed with HA (68). The stratified structure resulted in a 
smooth stress distribution and distinct cells adhesion within the implant. Further 
scaffolds are in shape of films, hydrogels, sponges or foam porous scaffolds, 
meshes and micro/nanofibers.  
The surface of an implant has been also modified with nanocomposites which 
successfully increased scaffold porosity, surface area, and roughness resulting in 
superior physicochemical properties, increased protein adsorption and nutrient 
exchange (67,69). The bioactive agents such as mesenchymal stem cells (MSC), 
tenocytes, dermal fibroblasts have been also used to improve implant stability 
(61,66). Next, several growth factors have been used including transforming 
growth factor-b (TGF-b), growth differentiation factor (GDF), platelet derived 
growth factor (PDGF), fibroblast growth factor (FGF), and connective tissue growth 
factor (CTGF) (61,66). Finally, proteins have been incorporated into the implants 
including bone morphogenetic protein (BMP-2,-7), parathyroid hormone related 
protein (PTHrP), Indian hedgehog (Ihh) as well as transcription factor (Sox9). All 
above mentioned bioactive agents have been shown to increase cell proliferation 
and protein expression as well as increased extracellular matrix (ECM) production 
in soft tissues (70,66).  
Surgical Implant and Bone Interface 
Surgical implant and bone interface is very important for the construct stability. 
Implants, such as orthopedic screw, plates and nails have been used in 
orthopedics as well as in orthodontics to repair injured bone and ceramic tooth. If 
bone insult is associated with a tissue loss, the defects are filled with either 
autologous or allogeneic bone grafts, depending on the size of a defect and 
preference of the surgeon. Injured bones, especially long, weight-bearing bones 
with a compromised structure, are unable to mechanically withstand the loading 
conditions. Therefore, surgical repair of long bones warrants additional mechanical 
support and ultimately creates an environment which stimulates bone healing. In 




Proper fixation can be only achieved with stable implants and literature defines 
implant stability as primary (mechanical) and secondary (biological). Implant 
stability has been widely studied in the literature and it has been found that the 
micro-motion between bone and implant exceeding 150 µm will negatively 
influence secondary stability (71-74). The excessive motion leads to increased 
tensile and shear stresses which are associated with a fibrous membrane 
formation around the implant, otherwise called fibroplasia (75,76). Fibroplasia can 
further result in further implant displacement decreasing implants secondary 
stability (75,76).  
Implant integration within bone has been found to be dependent three properties 
of the materials, including osteoinduction, osteoconduction and osseointegration 
(71,77-80). Osteoinduction has been defined as ability of the material to stimulate 
undifferantied and pluripotent cells to form the bone-forming cell lines (77). 
Osteoconduction has been defined as material ability to allow for bone tissue 
growth on the outer surface as well as within the pores and interconnected 
channels (77-80). Both terms are difficult to differentiate under in-vivo conditions, 
because injury created during implant placement or bone fracture begins cellular 
and extracellular bone healing cascade which already contain osteoinductive 
growth and differentiation factors (77,81,82).  
Osseointegration has become one of the most important terms defining bone and 
implant interface (71,77-80). This term has been widely studied in orthodontic 
surgery as well as less frequently in orthopedics (80,83-88). The pioneers who 
discovered the process are Brånemark et al, however Albrektsson et al evaluated 
the process under light microscope and defined it as direct contact between bone 
and implant (89,90). In order to say that an implant is well osseointegrated, direct 
bone formation line around the implant has to be really thin and ranged between 
10 and 20 µm (77). It can occur directly on the implant as direct osteogenesis or 
from surrounding bone as distance osteogenesis (71). Osseointegration is strongly 
associated with osteoinduction and osteoconduction (71,77). The biomechanical 
definition of osseointegration describes it as a process which leads to rigid fixation 
achievement of the alloplastic material which can be maintained during physiologic 
loading (91).  
Osseointegration process has been further distinguish in several biologic stages 
which are corresponding to bone healing. Those include hematoma formation, 
mesenchymal tissue development, intramembranous woven bone formation as 
well as lamellar bone formation (72,92). First stage is initiated with internal 
bleeding caused by implant insertion. Blood cells involving red blood cells, platelets 
as well as inflammatory cells such as polymorphonuclear granulocytes and 
monocytes reach the implant surface through extravascular migration (82).  
Migrated cells are being entrapped on implants surface and activated there. 




insulin like growth factor (IGF I and II), fibroblast growth factor (FGF), transforming 
growth factors beta (TGF-β), and platelet derived growth factor (PDGF) (82). Bone 
morphogenetic protein-2 and -7 that belong to TGF-β family have gained a special 
interest in orthopedic research due to their excellent osteoinductive properties. 
Activation of platelets induces several morphological and biochemical changes 
which consist of adhesion, aggregation as well as induction of phosphotyrozine, 
intracellular calcium increase, and phospholipids hydrolysis (82). Present cellular 
material ultimately shapes a fibrin matrix which works as a biologic and 
osteoconductive scaffold that also stimulates osteogenic cells to produce bone 
around the implant (osteoinduction)(82).  
Originally created matrix consist of poorly mineralized osteoid tissue structurally 
similar to bone cement lines and laminae, which forms a continuous 0.5 mm thick 
layer containing mainly calcium, phosphorus, osteopontin and bone sialoprotein 
(92). This thin osteoid tissue layer is being gradually calcified by osteoblasts 
directly on implants surface. Osteoblasts furthermore support this process by 
collagen matrix deposition (92). Calcification process is followed by the vascular 
and stem cells invasion in the non-calcified spaces (93). Vascularization is a vital 
part of ostoegenesis which has a significant impact on osseointegration process 
(94,95).  
Direct and distance osteogenesis occurs simultaneously with host bone resorption 
conducted by osteoclasts and the processes are separated with a clear 
demarcation line. Early mineralized osteoid tissue is being gradually transformed 
into a woven bone which not only is a space filler but also maintains integrity 
between host tissue and implant providing a mechanical support during the early 
loading phase (94,95). Three-dimensional woven bone works furthermore as a 
scaffold for cell attachment and bone deposition (94,96). These early processes 
related to bone formation begin as soon as 10-14 days after implantation (95). 
Within three months after the surgery, woven bone is being gradually remodeled 
into a lamellar bone (95). During the remodeling phase, new osteons circle around 
the implant with long axis parallel to implants surface. Osseointegration of an 
implant is confirmed with a thin line of bone containing osteoclasts, osteoblasts, 
mesenchymal stem cells as well as lymphatic/blood vessels in immediate 
surroundings. This line can further extend up to 1 mm away from implants surface 
(77,96).   
Factors Affecting Osseointegration 
Osseointegration is a complicated process which has been found to be positively 
influenced by several factors such as topography of implant surface, material, 
shape, length, diameter, material surface treatment and coatings (hydroxyapatite, 
bone morphogenetic protein-2) (97), status of adjacent bone (98), mechanical 




such as bone grafting, osteogenic biological coatings (99-101) as well as 
pharmacological agents such as simvastin and bisphosphonates (102,103).  
Macroscopic and microscopic topography of the implant has a vital impact on 
integration with adjacent bone. It has been proven that a rough surface of the 
implant stimulates osseointegration through several known mechanisms. Rough 
surface regulates osteoblast activation, proliferation and differentiation and these 
processes have been associated with activation of integrin receptors that bind to 
sequences/domains arginine-glycine-aspartate (ArgGly-ASP or RGD) of proteins 
(104,105). These Arg-Gly-Asp or RGD are expressed in several bone matrix 
proteins, including collagen I, fibronectin, osteopontin and bone sialoprotein. After 
implantation they are immobilized on material surface to promote cell adhesion via 
ligand receptor reaction (105,106). Activated integrins regulate phosphokinase C 
and A through phospholipase C and A2 pathways (104).  
Rough surface have been further associated with a higher expression of bone 
formation indicators such as osteocalcin and alkaline phosphatase (101). It also 
increases implant area in contact with host bone (BIC) supporting primary stability 
(107,108). Several methods such as spraying with titanium plasma, coating with 
hydroxyapatite, machine processing such as polishing, sandblasting and acid 
etching have been described to increase roughness of the surface (108,109).  
Smooth surface on the other hand induces more commonly distance osteogenesis 
in contrast to rough surface (110). Optimal size of microscopic pores an implant 
have been defined as 80 µm and above to enhance bone formation on implants 
surface (111). Recent studies have further shown that utilizing multiple surface 
topography such as a combination of micro and nano topography even more 
enhances osseointegration process. Nano pores have a direct impact on  selective 
adhesion of osteoblasts and positively influence their proliferation and 
differentiation (112). Interestingly, even small amount of micro motion (around 30 
µm) has been associated with enhanced osseointegration, however any motion 
above 150 µm significantly impairs the process (72-74).  
Gap size between implant and bone also influences osseointegration process. If 
an implant is placed in a tight contact with bone, only poor bone formation or even 
bone resorption has been observed, whereas presence of a small gap between 
implant body and host bone allows for a new trabeculae formation and therefore 
supports biological fixation. Gaps should however not exceed 500 µm to not 
reduce the quality of newly formed bone as well as to not delay gap filling process 
(95,113). Increased gap size significantly reduces bone and implant contact 
surface (BIC) which has been defined as significant parameter of osseointegration. 
The process can be also evaluated with bone density measurements, 
histomorphometry, mineral apposition rate as well as biomechanical tests such as 




The type of material has also a significant influence on osseointegration. To the 
physical properties which are of importance in the process belong materials 
modulus, ideally would be similar to cortical bone, high volumetric porosity (70-
80%), high frictional characteristics as well as excellent biocompatibility (114). 
Recently discovered porous tantalum (c.p. tantalum) has been found to be 
currently the best osseointegrative material (114). Another method to enhance 
osseointegration, material coatings, such as hydroxyapatite coating which has 
been also shown to significantly stimulate the process due to excellent 
osteoconductive and osteoinductive properties.    
The literature provides several factors that in contrast have a negative impact on 
osseointegration process, and those include previously mentioned excessive 
micro motion (above 150 µm) and related to it increased interfacial strain, 
inappropriate porosity of the porous coating, radiation therapy (76, 114-116), 
medications such as cyclosporine A, methotrexate, cis-platinum, warfarin, low 
molecular weight heparins as well as non-steroidal anti-inflammatory drugs 
(NSAID) (116-122). The most common nonselective COX-1 and COX-2 inhibitors 
include diclofenac and phenylbutazone. Diclofenac delayed bone healing in 
cortical and cancellous bone around titanium implants inserted in the rats after 
continuous administration for 5 days (122). Phenylbutazone on the other hand 
reduced the mineral apposition rate in horses after 14 days of continuous 
administration (123).  
Further negative for osseointegration factors include osteoporosis, rheumatoid 
arthritis, advanced age, nutritional deficiency, smoking and renal insufficiency 
(124-127). In osteoporosis, the balance between anabolic and catabolic bone 
metabolism is impaired, causing increased activity of osteoclasts and reduced 
neovascularization process (81). All of above-mentioned factors lead to failure of 
peri-implant osteogenesis which has been associated with decreased number and 
activity of osteogenic cells, increased osteoclastic activity, imbalance between 
anabolic and catabolic local factors, abnormal bone cell proliferation rate as well 
as impaired vascularization of peri-implant tissue (97). Osseointegration is a 
dynamic process named otherwise as biological fixation because it occurs over 
time after implant placement and it results in secondary stability of the implant. 
Implant Stability in Bone 
The bond between implant (orthopedic screw or dental implant) and bone is 
defined with primary and secondary stability. Primary stability is obtained by the 
implant immediately after placement in bone and it has been influenced by several 
factors such as surgical technique, implant design, surface texture, loading and 
related to it micro motion as well as quality of surrounding bone (128-131). Primary 
stability has been also defined as “mechanical stability” because occurs 
immediately after implant placement and it is not affected by the osseointegration 




mechanical properties, it can be easily evaluated under in-vivo as well as ex-vivo 
conditions.  
One of the factors strongly correlated with primary stability is surgical technique 
and especially insertional torque. Surgical drilling not only causes damage to 
surrounding bone but also increases temperature within adjacent tissue (132). 
Death of bone cells occurs when temperature exceeds 47 °C over a time of 1 min 
(133). Furthermore, surgeons commonly undersize drilling osteotomy prior to 
implant placement to increase insertion torque during implant placement and 
increase primary stability. Several studies have found that better primary stability 
is achieved when osteotomy is 10% smaller than the outside diameter of an 
implant. Further decreasing the size of osteotomy to 25% of the outside diameter 
has not given additional benefits (134).  
A high insertional torque of dental implants has also been found to have a 
destructive effect on direct peri-implant tissue causing micro fractures and 
subsequent bone resorption (135-137). Orthodontic research recommends a lower 
insertional torque because it is more osteoprotective, resulting in better 
osseointegration over time (138-140).  
Situation looks slightly different in orthopedics. Several articles in orthopedic 
research have looked at the difference in primary stability of self-tapping and non-
self-tapping screws. Self-tapping screws have been found to have a significantly 
higher insertional torque and through that higher primary stability (128,141-143). 
Higher insertion torque was attributed to torque required to cut the threads in bone 
with a cutting flute at the top of implant (128,141). Non-self-tapping screws lack 
this cutting flute and their placement is preceded with pre-tapping process which 
is conducted using a tap device (128,141). The tap devices have longer threads 
creating a micro gap between screw and bone, which results in a significantly lower 
insertion torque but also in a micro motion and increased interfacial strain 
(130,131,135,141). Micro gap decreases further the BIC and leads to a lower 
primary stability of the implant (144).  
Encountered discrepancies between the stability of an implant in orthodontics and 
orthopedics can be explained with bone anatomy and implant design. The 
craniofacial bones contain mostly cancellous bone which has lower bone mineral 
density (BMD) in contrast to the long bones which due to a higher content of 
cortical bone, have higher BMD (145,146). Lower BMD has been also associated 
with lower BIC. Both have been strongly correlated with primary implant stability 
and insertion torque (IT) (147,148). Because the craniofacial bones have lower 
BMD, the peak IT is generally lower than in load bearing bones, and they are more 
prone to the destructive effect of higher IT. Furthermore, increased IT does not 
result in increased BIC and primary stability of the implants used in orthodontics. 
In orthopedics denser bones are more resistant to the higher IT which results in 




Primary stability can be evaluated under in-vivo as well as ex-vivo conditions using 
common mechanical testing methods such as resonance frequency analysis 
(RFA), percussion test (Periotest), insertion torque (IT) and cutting torque 
resistance analysis (CRA). Under Ex-vivo conditions  followed methods can be 
utilized including pullout, pushout and bending. Results of implant primary stability 
measured with RFA under in-vivo conditions are displayed as implant stability 
quotient (ISQ) which is a graphical (Figure 1) and numerical representation of 
implant stability and related micro motion. ISQ ranges from 1 to 100, where 1 is a 
mobile implant and 100 implies maximum stability. ISQ cutoff has been defined as 
47 and below this value the implant has no sufficient primary stability (149,150).  
As new bone is being formed around the implant, secondary stability is being 
achieved (Figure 1, all figures are placed in the appendix) (85). Secondary stability 
is related to long-term stability of the implant and bone interface and it is obtained 
during the process of osseointegration (132,137). Secondary stability has been 
named otherwise “biological stability” due to healing influence on the process 
(132). Since both processes occur simultaneously, the same factors which impact 
osseointegration, will have an impact on secondary stability (79,97-103).  
 
Several studies have found a significant association between primary and 
secondary stability (132,135,137). In other words, lesser micro motion leads to  
better osseointegration. Recent systematic review reports a correlation between 
primary and secondary stability measured with RFA to be significant and equaled 
0.847 (137). Several other studies which looked at survival rate of dental implants 
with or without primary stability have found that primary stability is not the only 
factor influencing osseointegration (131,132).  
The literature does not provide a specific definition of lack of primary stability. One 
study classified lack of primary stability of the dental implants into four categories, 
and those included no rotation [1], light rotation with a feeling of resistance [2], 
rotation without resistance [3], and rotation combined with lateral oscillation [4] 
(151). The implants which were assigned to second, third and fourth category were 
defined as implants having no stability (151). Other research defined lack of 
stability as a torque below 10 Ncm and slight lateral mobility (152).  
Another recent study looked at 3111 dental implants and reported 79.8% survival 
rate of the implants with no primary stability (71 out of 89) over 3 years compared 
with 93.4% (2823 out of 3022) survival rate of the implants with primary stability 
over 3 years (153). More detailed analysis of the without primary stability revealed 
a significant difference in survival rate of implants coated (91.8%) and not coated 
(53.6%) with Hydroxyapatite (HA) (153). This confirms relevance of texture of the 
implant surface in osseointegration process as well as implies that HA coating may 




Rough surface as a beneficial effect in obtaining osseointegration similarly among 
the implants with or without primary stability. The process can be evaluated with a 
limited number of mechanical tests under in-vivo as well as ex-vivo conditions, 
including resonance frequency analysis (RFA) or percussion test (Periotest). 
Significantly more tests can be conducted to evaluate the process ex-vivo, 
including peak reverse torque (PRT), pullout, pushout, torsion and bending test.  
In-Vivo and Ex-Vivo Stability Testing 
Mechanical testing of implant stability provides several options which can be 
conducted under in-vivo as well as ex-vivo conditions (88,154-157). The tests 
include resonance frequency analysis (RFA), percussion test (Periotest), insertion 
torque (IT) as well as cutting torque resistance analysis (CRA). Those tests 
evaluate implants micro motion as well as encountered resistance during 
placement of the implant. The tests have been therefore used to evaluate primary 
as well as secondary stability. 
The method most commonly used in dentistry to evaluate primary and secondary 
implant stability is resonance frequency analysis (RFA). It has been developed and 
described by Meredith et al in 1998 (154). It utilizes an L shaped transducer device 
connected with a vibrating element and receptor. The vibrating element applies a 
continuous and repeatable impact wave or a single impact force to the assessed 
implant and the receptor in device records resonance signal from the implant and 
bone component (154,158). Originally, the resonance was measured in Hz unit, 
but over time this was replaced by a new, developed by Osstell et al., ISQ unit 
which corresponds with implant stability quotient (149,150).  
Another test utilized in orthodontics to measure primary stability is Periotest. The 
test was originally developed and described by Schulte et al. to evaluate natural 
tooth mobility (155). The device contains a metallic rod that applies controlled 
tapping force to the object. The response to tapping is measured by a sensor within 
the hand piece and it is converted to periotest value (PTV). PTV ranges from -8 
(low mobility) to +50 (high mobility) (88,155). The PTV values of an 
osseointegrated implant fall in the range of -5 to +5 (88). The scientific articles 
have assumed that PTV precisely reflects the BIC (156).  
Cutting Torque Resistance Analysis (CRA) was developed by Friberg at all in 1995 
(157). This method measures a torque required to cut a thread in the implant 
osteotomy site during a low-speed threading. It gives a valuable information about 
the quality of adjacent bone (157). CRA has been used significantly less frequently 
than insertion torque (IT) measuring method. The methods described above are 
used primarily in orthodontics and the research in orthopedics is lacking.  
Insertion torque (IT) measures peak resistance torque during implant placement 
(142,158,159). IT has been measured only during implant placement therefore it 




implant (142). It has been widely studied in orthodontics as well as in orthopedics. 
Utilization of this method has developed recommendations regarding optimal 
insertion torque during specific implant placement. For instance, the orthodontic 
studies recommend optimal torque for implant placement of 0.032 Nm (159). The 
IT values in orthopedics are significantly higher and dependent on the size of 
placed screw within the orthopedic plate, e.g. 1.70 Nm for 3.5 mm screw or 4.0 Nm 
for 4.5 mm screw (160,161). It  is a feasible method which can be used to assess 
primary stability of an implant under in-vivo as well as ex-vivo conditions.   
Ex-Vivo Stability Testing 
Hence secondary stability occurs over time, it can be only evaluated after the 
implant had been placed in tissue. Based on above provided literature review, 
osseointegration process occurs as early as 14 days after implantation and it may 
take up to 3 months. There are several mechanical tests which can be utilized 
under both in-vivo as well as ex-vivo conditions and most significant are described 
in the paragraph above. Several other methods not only test the implant 
integration, but also the integrity of entire construct repaired with the implant, can 
be only conducted under ex-vivo conditions. Those methods require a mechanical 
testing system such as Instron machine and include pullout, pushout, torsion and 
bending tests. Peak reverse torque can be also performed using a torque 
measuring screwdriver.  
Peak reverse torque (PRT) has been successfully used in the research on 
orthodontic as well as orthopedic implants (86,87,129-131,162,163). This method 
measures torque required to remove an implant from bone and to break the bond 
between bone and osseointegrated implant (86,87,129-131,162,163). PRT has 
been shown to be strongly influenced by the grade of osseointegration (86,129-
131). It is a very sensitive method to evaluate not only a single orthodontic or 
orthopedic implant but also the entire orthopedic plate-screw stability as it has 
been recently proven (86).  
Osseointegration has been negatively influenced by loading conditions and micro 
motion of the implant as stated in the paragraph above. The differences in loading 
between single implants used to fix dynamic compression (DC) orthopedic plate, 
should affect the osseointegration process (86). Hence, the axial strength of a DC 
plate can be predicted with axial strength of the weakest screw in the construct, 
PRT provides more insight information about the stability of entire tested construct 
(86).   
Further mechanical testing methods discussed in this literature review are used to 
test entire constructs such as a long bone repaired with orthopedic plate and 




cartilage with laryngeal clamps (164) or collateral ligaments with the suture 
anchors (165). The tests have to be conducted under ex-vivo conditions because 
their aim is to test construct stability until it fails (128,164,166-168). Pullout tests 
have been used to test single implants or entire constructs in several orthopedic 
as well as soft tissue studies (128,164,166-168). Pullout is caused by displacement 
of the actuator in the testing frame which applies tensile stresses to tested implant 
or entire construct (169). Tests are being conducted until implant is being entirely 
removed from tissue and construct fails (164,166,167). Rate of displacement 
should be adjusted accordingly to the testing method created for specific construct.  
During tests several mechanical parameters are measured, and the most 
important involve maximum tension load, actuator displacement and construct 
stiffness. Maximum tension load has been defined as maximum tensile load 
measured at implant or construct failure (170). The actuator displacement 
corresponds with distance measured from its original position to its position at the 
end of conducted study and construct stiffness corresponds with calculated load 
over displacement slope (164,170).  
A recent study used this method to evaluate stability of rostral laryngeal 
advancement constructs (tie-forward), the surgery commonly performed on horses 
suffering from dorsal displacement of soft palate (DDSP) (164). The method of 
construct failure was associated with the suture and cartilage interface, due to 
shear stresses applied by the suture to surrounding tissue. As a solution to this 
problem a novel technology laryngeal clamp have been proposed (164).  Laryngeal 
clamps distribute tensile stress applied to them during swallowing, over a larger 
area and therefore protect thyroid cartilage (164). The clamps increase stiffness of 
entire construct, reducing the risk of construct displacement in postoperative 
period (164).  
Another test utilized to evaluate single implants or entire construct in bone as well 
as soft tissue is torsional loading (169-172). In torsion, load applied to the 
specimen causes its rotation about axis, previously specified in methodology (172). 
Torsion creates a complex composition of internal stresses which involve 
compression, tension and shear. Maximum values of all stresses have been found 
on the surface of tested specimen and they are being reduced towards neutral 
axis. Maximum shear stresses act on a plane perpendicular and parallel to neutral 
axis, whereas maximum normal stresses (tensile and compressive) act 45° to the 
axis of tested specimen. A recent study compared stability of an interference 




cadaveric model. The study utilized torsion method to assess the stability of both 
implants with the conclusions that unicortical button provides a higher stability 
fixation (172).   
 
Bending tests have been widely used in biomechanical testing in orthopedic 
research (166,173-175). The unique testing method also generates composition 
of stresses which involve compression and tension (169,170). During bending, 
compression stress is applied to upmost surface of the specimen, adjacent to the 
actuator and tension is applied to opposite site, far from actuator (169,170). This 
method has been used to test the entire constructs as opposed to single implant 
(165,173-175). Current mechanical testing devices are capable of conducting two 
different bending methods including 3- and 4-point bending.  
 
The difference between 3- and 4-point bending is related to number of loading 
points attached to actuator (175). In 3-point bending, the actuator contains one 
loading point between two holding points, creating therefore three stressing points 
on the tested specimen. Bending moment is concentrated in the area directly under 
one loading point (175). This results in a higher focused bending stress. In 
contrast, in 4-point bending, the actuator contains two loading points and two 
holding points, therefore four stress points (165,173-175). Bending moment is 
equally distributed between two loading points, increasing the distribution area of 
bending stress (175). A recent study utilized 4-point bending method to evaluate 
bending stiffness of metacarpophalangeal collateral ligament repair construct 
which utilized suture anchors (165). The study compared the ultimate bending 
resistance of native collateral ligaments and compared it to the constructs repaired 
with the suture anchors. Further findings included no significant difference in 
resistance to bending between constructs repaired with different suture anchors 
(165). Conclusion of this study was that suture anchors can be used to enhance 
immediate postoperative stabilization of injured collateral ligaments (165).  
 
The literature review provides several options for mechanical testing of implant 
stability. Methods can be utilized to test the bone or soft tissue constructs as well 
as single implants. Depending on question stated in the research and implant of 
interest, the method can be chosen and adjusted accordingly. All the tests can be 
used in a simple load to failure mode or in cycles with relaxation and creep mode. 
In some situations, cyclical tests mimic in-vivo conditions better than simple load 






Surgical implantation leads to tissue injury and results in cellular death adjacent to 
surgical site. Improved healing through enhanced cellular regeneration will 
stimulate implant stabilization within tissue. Bleeding is the first step of healing in 
all tissues described above and it has direct influence on the healing process. 
Limited bleeding after tissue injury in avascular tissues such as cartilage and 
ligament makes the integration process challenging. This literature review 
provided several novel approaches on cartilage, ligament as well as in bone to 
improve implant integration. Current knowledge reveals that design of implant, 
close to native structure of targeted tissue has a better chance for integration. This 
however cannot always be achieved, and, in such situations, bioactive coatings 






Figure 1-1. Implant stability in bone. 
Graph presents gradual changes in primary (mechanical) vs secondary (biological) 
stability of an implant placed in bone. Primary as well as secondary stability have 
an influence on total implant stability. There is a decrease in total stability between 
2 and 4 weeks after implantation. Graph imported from Raghavendra S, et al. Early 
Wound Healing Around Endosseous Implants: A review of the Literature. The 
International Journal of Oral & Maxillofacial Implants 2005; 20(3):425-430. The 
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CHAPTER TWO  
EX-VIVO MECHANICAL TESTING OF NOVEL LARYNGEAL 
CLAMPS USED FOR LARYNGEAL ADVANCEMENTS 
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Stable suture and cartilage interface is vital for implant integration and directly 
influences the outcome of surgical procedures. Rostral laryngeal advancement 
(tie-forward) is a very common procedure in horses that suffer under dorsal 
displacement of the soft palate. This procedure relies on anchoring thyroid 
cartilage to basihyoid bone and advancing entire larynx in the rostral and dorsal 
direction. Suture implants aim to mimic the action of thyrohyoideus muscles which 
have been proven to be dysfunctional in horses diagnosed with the disease. 
Failure of the procedure has been further attributed to suture and thyroid cartilage 
interface and more precisely to suture pulling through the cartilage. The conducted 
study aimed to evaluate the stability of tie-forward constructs performed with 
standard suture implants as well as suture implants stabilized with suture buttons. 
Further objective embraced report of construct failure mode and comparison of the 




Rostral laryngeal advancement, also known as laryngeal tie-forward, is used to 
treat horses for intermittent dorsal displacement of the soft palate and has a 
morbidity rate of about 6%. We hypothesized that a novel laryngeal clamp would 
prevent morbidity associated with the sutures tearing through the thyroid cartilage. 
Larynges (n = 35 horses) were used for ex-vivo testing. For uniaxial testing, 15 
equine larynges were tested in one of three laryngeal tie-forward constructs 
[standard laryngeal tie-forward; modified laryngeal tie-forward using a suture-
button; and modified laryngeal tie-forward using a laryngeal clamp]. For biaxial 
testing, 20 larynges were tested in one of two treatment groups: laryngeal tie-
forward and laryngeal tie-forward using a laryngeal clamp. Constructs were tested 
in single cycle-to-failure. Statistical analyses were performed using ANOVA for 
uniaxial testing and t-tests for biaxial testing.  
Results 
The laryngeal tie-forward using a laryngeal clamp construct was superior to 
laryngeal tie-forward and laryngeal tie-forward using a suture-button constructs in 
resistance to pullout in uniaxial testing. The laryngeal tie-forward using a laryngeal 
clamp presented a significantly different method of failure than the standard 
laryngeal tie-forward in the biaxial testing. Failure modes for each construct were 
primarily by suture failure at the clamp (laryngeal tie-forward using a laryngeal 
clamp), suture pullout through the thyroid cartilage, or, less commonly, tearing of 
the cricothyroid ligament (laryngeal tie-forward). In uniaxial testing, the laryngeal 
tie-forward using a laryngeal clamp failed most commonly due to tearing of the 
cricothyroid ligament, whereas the standard laryngeal tie-forward and the 
laryngeal tie-forward using a suture-button failed due to the tearing of the cartilage. 
The laryngeal clamps provided greater stiffness, load at yield, and tensile stress at 





Laryngeal clamps may offer an alternative to standard methods of anchoring the 
thyroid cartilage when performing the laryngeal tie-forward procedure. Further 
testing and clinical trials are needed to elucidate the utility of the laryngeal tie-
forward using a laryngeal clamp.   
Introduction  
Intermittent dorsal displacement of the soft palate (IDDSP) is a multifactorial 
disease occurring in 10-20% of racehorses (1-7) and 28% of competing draft 
horses (8). Females and young horses (2 - 4 years old) have been reported to be 
more affected than male and older horses (9). The etiology of this disease is 
multifactorial, and proposed causes include reduced activity of the thyrohyoideus 
muscles (10-12), reduced activity of the palatine and palatopharyngeal muscles 
(13), and reduced activity of the hypoglossal nerve (14).  
The suggested medical and surgical treatments of affected horses are many, 
because the pathophysiology associated with IDDSP is complex (15-22). Surgical 
treatments include myectomy of the laryngeal retractor muscles (18-20), 
staphylectomy (21,22), palatoplasty (21,22), and rostral advancement of the 
larynx, commonly referred to as the laryngeal tie-forward (LTF) procedure (10-12). 
The success rate of the LTF procedure in preventing IDDSP is reported to be in 
the range of 80-82%, which is better than the rate associated with the other 
procedures (11,12). This procedure advances the larynx dorsally and rostrally 
using a biaxial suture construct in which two non-absorbable sutures, one inserted 
through the caudoventral aspect of the right lamina of the thyroid cartilage and the 
other inserted in a similar manner through the left lamina of the thyroid cartilage 
and anchored to each other at the basihyoid bone, mimic the action of the 
thyrohyoideus muscles (10,11). The incidence of complications associated with 
this surgery has been reported to be about 6%, and the primary complication has 
been the failure of one or both sutures to retain the larynx in its new position 
(23,24). 
The LTF procedure is most often performed using polyethylene or polyester 
sutures (10,11,25,26), and according to previous reports, the procedure can fail if 
one or both sutures break or tear through the thyroid cartilage. The LTF procedure 
reported by Woodie et al. (2005) and Cheetham et al. (2008) has been modified 
recently in an attempt to increase the mechanical strength of the construct 
(5,11,26,27). Rossignol et al. (2012) modified the procedure by anchoring the 
suture to the thyroid cartilage with metallic implants (i.e., "suture buttons"; LTFB), 
which resulted in improvement of the mechanical stability of the construct during 
mechanical testing (27). Rossignol et al. (2012) found, however, that the strength 
of the modified LTFB construct was inferior to that of the standard LTF construct 
and reported that the method of failure in both types of constructs was pullout of 




pullout from the thyroid cartilage is needed, because the method of failure of the 
LTF procedure in all tested constructs has been pullout of the construct through 
the thyroid cartilage.  
We hypothesized that a custom-designed, novel laryngeal clamp (LTFC) would 
distribute tensile forces over a large area of the thyroid cartilage, thereby 
eliminating morbidity associated with failure at the suture-cartilage interface. The 
objectives of the study were to design and manufacture a novel laryngeal clamp 
and to study the mechanical characteristics of the LTF constructs (LTF, LTFB, 
LTFC) anchored to only one lamina of the thyroid cartilage (uniaxial testing) and 
to mechanically test the strength of two different constructs (LTF, LTFC) anchored 
to both laminae of the thyroid cartilage (biaxial testing). We expected that the 
difference in ex-vivo uniaxial mechanical testing between the constructs would be 
significantly different but testing between right-sided and left-sided constructs 
would not be significant. We expected the results of ex-vivo mechanical testing 
between the standard construct and the construct modified with clamps would be 
significantly different in biaxial mechanical tests.   
Materials and Methods 
Preparation of the larynxes 
Thirty-five larynges, each with its hyoid apparatus attached, were collected from 
horses within 24 hours after the horses were euthanized for a reason unrelated to 
the respiratory tract. Of these 35 larynges, 15 were used in proof-of-concept, 
uniaxial mechanical studies, and 20 were used in biaxial mechanical studies. 
Signalment data, including age, weight, breed, and sex, were available for horses 
supplying the larynxes (n = 20) used for biaxial testing. Larynges were frozen at -
20o C until mechanical testing was performed (25,27-32) and were thawed at room 
temperature for 24 hours prior to testing. The larynges were wrapped in isotonic 
saline-soaked gauze after they were thawed to keep them moist until tested.  
Sample Measurements Collection 
Before performing uniaxial tests, the thickness of the laminae of 15 thyroid 
cartilages was measured at 3 locations, 10 mm apart, on the caudoventral margin 
of the laminae, close to the insertion of the sternothyroideus muscles, using a 
digital calipera. The thickness of the laminae of the 20 thyroid cartilages used for 
biaxial testing was measured in a similar fashion but in 10 different locations on 
each lamina to assess the properties of the thyroid cartilage (Figure 2-1, Table 2-
1, all figures and tables are placed in the appendix). Locations 1 and 2 were at the 
ventral and axial aspect of the thyroid cartilage. Locations 3 to 5 were at the dorsal 
aspect of the thyroid cartilage, and locations 6 to 10 were at the caudoventral 
aspect of the right and left laminae, close to the insertion of the sternothyroideus 
muscle. Measurements were obtained to determine the space between the arms 





Uniaxial testing  
Fifteen larynges were randomly assigned to one of three treatment groups 
according to the construct tested, and each side of the larynx to which the construct 
was applied was tested separately. Uniaxial tests on the suture-cartilage interface 
included the following: 1) standard LTF using USP no. 5 polyester sutureb, 2) LTF 
modified with a suture button (LTFB), and 3) LTF modified with a custom-designed 
laryngeal clamp (LTFC) (Figure 2-2). The uniaxial testing was performed to 
evaluate the performance of a single implant anchored to the thyroid cartilage and 
to assess the difference in the mechanical performance between the left and right 
laminae of the thyroid cartilage.   
Biaxial testing 
Twenty larynges were randomly assigned to one of two treatment groups 
according to the construct tested, and both sides of the larynx to which the 
construct was applied were tested simultaneously. The constructs tested included 
the LTF construct using USP no. 5 polyester sutureb and the LTFC. The 
ceratohyoid and thyrohyoid bones were removed from the basihyoid bone, which 
was mounted on the loading frame of an electromechanical testing machinec. The 
free ends of the sutures passing through the laminae of the thyroid cartilage were 
attached to the basihyoid bone (Figure 2-3). 
Laryngeal Tie-forward (LTF) 
The LTF procedure was performed in a manner similar to the technique described 
by Woodie et al. (2005) and Cheetham et al. (2008) (11, 12). Using this technique, 
USP No. 5 polyester sutureb was inserted twice through the right or left lamina of 
the thyroid cartilage, at the caudoventral aspect of the lamina, using a ½-circle, 
trocar-point, needled to create a single loop around the caudoventral margin of the 
lamina close to the tendon of insertion of the sternothyroideus muscle (Figure 2-
3).  
Laryngeal Tie-forward modified with suture buttons (LTFB) 
The LTFB procedure was performed in a manner similar to the technique 
described by Rossignol et al. (2012) (27). Using this technique, USP No. 5 
polyester sutureb was threaded through the eyelet of the suture-button (2-mm thick 
rounded plate with 2, 1.5-mm diameter holes), and the free ends of the sutures 
were inserted through the eye of a ½-circle, trocar-point needled The needle was 
passed once through the caudoventral margin of the right or left lamina of the 
thyroid cartilage in a manner similar to that described using the LTF, and by 
applying tension to the suture, the button became seated firmly on the ventral 
aspect of the caudal edge of the thyroid cartilage (Figure 2-4).   
Laryngeal Tie-forward modified with novel laryngeal clamp (LTFC) 
The laryngeal clamps, composed of 316-stainless steel, were a broad U-shaped 




thyroid cartilage. One arm of the clamp was 10 mm long, the other was 14 mm 
long, and the gap with the “U” between the arms was 7 mm (Figure 2-5). The clamp 
was inserted around the caudoventral border of the right or left lamina of the thyroid 
cartilage close to the site of insertion of the sternothyroideus muscle, so the short 
arm lay dorsal to the lamina and the long arm ventral to the lamina. The dorsal arm 
contained two, 2-mm diameter holes spaced 2 mm apart, which together served 
as an eyelet for the suture, and the ventral arm contained a slit through which the 
suture was easily passed (Figure 2-5). The suture was attached to the clamp by 
threading one end of the suture through one hole in the eyelet and the other end 
through the adjacent hole, so the ends emerged between the arms of the clamp. 
The ends of the suture were then threaded through the eye of a ½-circle, trocar-
point needled, which was passed once through the right or left lamina of the thyroid 
cartilage close to the insertion of the sternothyroideus muscle. The needle 
emerged approximately 5-10 mm rostral to the caudal margin of the lamina (Figure 
2-6). The needle was removed, and the ends of the suture were passed through 
the slit in the dorsal arm of the clamp. The clamp became seated firmly around the 
caudal edge of the thyroid cartilage at the site of insertion of the sternothyroideus 
muscle when tension was applied to the suture (Figure 2-6).  
Uniaxial Biomechanical Testing 
Laryngeal constructs were tested in a single cycle-to-failure test using an 
electromechanical testing system with a 5-kN maximum load cellc. The larynges 
were mounted to the machine as previously described (25). Briefly, a 3.2-cm 
diameter cylinder of polyvinyl chloride (PVC) was passed into the lumen of the 
larynx, and two 3.5-mm diameter, 40-cm long Steinmann pins were placed through 
the larynx and cylinder perpendicular to the long axis of the cylinder and to each 
other. One pin was placed through the cricoid cartilage, and a second pin through 
the center of the thyroid cartilage, securing both cartilages firmly to the PVC 
cylinder, avoiding interference with the cricothyroid ligament.  
After mounting the cylinder and larynx on the loading frame of the 
electromechanical testing machine with the rostral portion of the larynx uppermost, 
(Figure 2-2), the ends of the suture were tied together around a 5-mm diameter 
steel bar attached to a custom-made holding grip, with a surgeon’s knot, and 
secured with 7 throws (Figure 2-2). The suture loop resided in the center of the 
steel bar during the testing of each specimen, to mimic the direction of the suture 
in-vivo and to maintain the repeatability of the testing conditions between the 
specimens. The pullout tests were performed at a distraction rate of 300 mm/min 
(25). The variables recorded for each construct included maximum load (N), 
stiffness (N/mm), extension at maximum load (mm), extension at the break (mm), 
extension at yield (mm), load at yield (N), tensile stress at yield (N/mm2), and 
tensile stress at maximum load (N/mm2). The maximum load was defined as the 
maximum force loaded to the point of failure of any part of the construct, and the 
stiffness was calculated from a load-displacement curve. Displacement was 




the tensile stress was defined as the force applied to the area of the thyroid 
cartilage.  
Three different modes of construct failure were observed and recorded, including 
tearing of the thyroid cartilage, tearing of the cricothyroid ligament, and breaking 
of the suture. The thyroid cartilage tore when the implant pulled through the 
cartilage. The cricothyroid ligament tore when the implant caused the thyroid 
cartilage to elevate and separate from the cricoid cartilage by tearing the 
cricothyroid ligament, resulting in little or no damage to the thyroid cartilage. 
Breaking of the suture, the third mode of failure, occurred at the knot of the loop 
around the steel bar.    
Biaxial Biomechanical Testing 
The constructs tested in biaxial loading mimicked one of two clinical constructs, 
LTF and LTFC. Both constructs were anchored and mounted on the Instron 
machinec in the manner described above. After removing the hyoid apparatus, the 
larynx was mounted on the upper loading cell of the electromechanical testing 
machine. For the LTF construct, the free end of the ipsilateral dorsal arm of the 
suture and contralateral ventral arm of the suture inserted through one lamina of 
the thyroid cartilage were advanced rostrally and dorsally to the detached 
basihyoid bone, which was mounted on the loading frame of the MTS testing 
machinec. The same procedure was performed on the contralateral side. The 
ventral arms of the right and left sutures were tied to each other around the ventral 
aspect of the lingual process, with a surgeon's knot, and secured with 7 throws. 
The dorsal arms of the right and left sutures were tied together in a similar fashion 
(Figure 2-3).  
To create the LTFC construct, both ends of each suture were advanced rostrally 
and dorsally to the ipsilateral side of the basihyoid bone (Figure 2-3). The four arms 
of the sutures were tied together around the ventral aspect of the lingual process 
of the basihyoid bone, with a surgeon’s knot, and secured with 7 throws. The 
pullout test was performed in a manner similar to that performed for uniaxial testing 
at a distraction rate of 300 mm/min. Three different modes of construct failure were 
observed and recorded and were the same as those observed during uniaxial 
testing. 
Statistical Analyses 
Statistical analyses were performed by using IBM SPSS Statistics 25e. Descriptive 
statistics were calculated for all variables for all treatment groups and included 
minimum, maximum, mean, and standard deviation. The normality of data 
distribution for each variable was performed by using the Kolmogorov-Smirnov test 
of normality. 
The thickness of the 3 sites measured on laminae of the thyroid cartilage of the 




samples T-test. The thickness of the 10 sites measured on the right lamina of the 
thyroid cartilage of the larynges used for biaxial testing was compared to the 
thickness of the left lamina by using a two-tailed independent samples T-test. The 
results were examined for homogeneity of variance, and each site was compared 
by using ANOVA and the Tukey’s Post-hoc test. The thickness was also correlated 
with the age, breed, and weight of donors by using a two-tailed Pearson 
correlation.  
 
For uniaxial tests, the differences in maximum load, stiffness, extension at 
maximum load, extension at break, extension at yield, load at yield, tensile stress 
at yield, and tensile stress at maximum load between the left and right testing side 
of the thyroid cartilage were examined for homogeneity of variance. The 
differences between each testing group were then analyzed by using ANOVA and 
Tukey’s Post-hoc test. The correlation between the construct and method of failure 
was examined by using Fisher’s exact tests.  
For biaxial tests, the differences between two constructs were compared by using 
a two-tailed independent samples T-test, and the correlation between the construct 
and method of failure was tested by using the Fisher’s exact test. The level of 
statistical significance was established at p < 0.05 and the power of the experiment 
design and test combination was calculated using PS softwaref in the reference to 
the results of maximum load during mechanical testing.  
Results 
Study Population 
The weight of the horses from which the 35 larynges were harvested ranged from 
450 to 650 kg (mean 570 ± 70.7 kg), and the ages of these horses ranged from 2 
to 29 years old (mean 14.8 ± 8.1 years). Information about the breed and sex of 
the donors was obtained only for the 20 larynges used in biaxial tests. The breeds 
of these 20 horses included Thoroughbred (11), American Quarter Horse (3), 
Tennessee walking horse (1), Warmblood (2), American Standardbred (1), 
Hanoverian (1), and Clydesdale (1). Ten donors were female, and 10 were 
geldings. 
Sample Measurements Collection 
The Kolmogorov-Smirnov test of normality of distribution showed the 
measurements of cartilage thickness to be normally distributed in all tested 
positions (p > 0.05). The Levene’s test for equality of variances revealed that equal 
variances in all variables could be assumed (p > 0.05). The descriptive statistics 
of the thickness measurements of the thyroid cartilage of the 15 larynges used in 
the single-side testing (i.e., uniaxial tests) revealed that the mean thickness of the 
caudoventral edge of the left thyroid cartilage lamina was 4.58 ± 0.7 mm. The mean 
thickness of the caudoventral edge of the right thyroid cartilage lamina was 4.70 ± 




cartilage of the 10 larynges used in biaxial testing revealed that the mean thickness 
of the caudoventral edge of the left thyroid cartilage lamina was 4.48 ± 1.3 mm. 
The mean thickness of the caudoventral edge of the right thyroid cartilage lamina 
was 4.50 ± 1.2 mm. The differences in the average thickness between the left and 
right laminae of the thyroid cartilage in the study population were not statistically 
significant (p > 0.05) (Tables 2-2 and 2-3).  
  
Significant differences were found in the thickness of the laminae of the thyroid 
cartilage among the different anatomical positions (p < 0.05). The position 
numbers 7 (L – 6.01 ± 1.2 mm; R – 5.89 ± 1.2 mm), 8 (L – 4.95 ± 0.8 mm; R – 4.99 
± 0.8 mm), and 10 (L – 6.47 ± 1.4 mm; R – 6.18 ± 1.6 mm) were significantly thicker 
than the rest of the anatomical positions (p < 0.05) (Table 2-1). These sites were 
at the caudal margin of the thyroid cartilage at the site of insertion of each 
sternothyroideus muscle (Figure 2-1). No significant correlation was found 
between the mean thickness of the caudoventral aspect of the margin of the 
laminae of the thyroid cartilage and the age and breed of the donors for any sites 
examined (p > 0.05). There was, however, a significant positive correlation 
between the mean thickness of the laminae and the weight of the donors (r = 0.78, 
p < 0.05) 
Uniaxial Biomechanical Testing 
Data was normally distributed and homogeneous for all variables (p > 0.05). The 
two-tailed independent samples T-test did not reveal significant differences in the 
results of biomechanical testing between the left and right side of the lamina (p > 
0.05) (Table 2-3). The yield on the load-displacement curve corresponded to the 
tearing of the thyroid cartilage (n = 22) or to the tearing of the cricothyroid ligament 
(n = 7).   
Uniaxial testing of the constructs revealed that the mean pullout strengths of the 
LTFC (207 ± 43 N) and LTF (199 ± 19 N) constructs were significantly greater than 
the mean pullout strength of the LTFB construct (176 ± 43 N) (p<0.05) and that the 
difference in the mean pullout strength of the LTFC construct did not differ 
significantly from that of the LTF constructs (p>0.05). Similarly, the mean load at 
yield point was significantly greater for the LTFC (161 ± 45 N) and LTF (168 ± 23 
N) constructs than that for the LTFB construct (139 ± 51 N) (p<0.05), but the mean 
load at yield point for the LTFC construct did not differ significantly from that the of 
the LTF construct. The results of the rest of the uniaxial mechanical testing were 
not significantly different between the treatment groups (p>0.05) (Table 2-4, Figure 
2-8).  
Fisher’s exact test revealed a significant correlation between the construct and 
method of failure (p < 0.05). Of the constructs modified with a laryngeal clamp, 
70% failed by tearing the cricothyroid ligament, and 30% failed by tearing the 
thyroid cartilage adjacent to the clamp. None of these constructs failed from the 




cartilage. Constructs modified with a suture button failed from tearing the thyroid 
cartilage (90%) or from breaking of the suture (10%). 
Biaxial Biomechanical Testing  
All variables, including biomechanical values, were normally distributed (p > 0.05). 
Tests for equality of variances revealed that equal variances in all variables could 
be assumed (p > 0.05).  
 
As occurred in the uniaxial testing, the yield on the load-displacement curve 
corresponded to tearing of the thyroid cartilage (n = 8) or to tearing of the 
cricothyroid ligament (n = 3). The LTF construct compared to the LTFC in the 
biaxial testing had a significantly higher mean maximum load (430.3 ± 64.84 N and 
367.9 ± 55N respectively), lower mean extension at yield (33.38 ± 8.9 mm and 
42.54 ± 7.81 mm respectively), higher mean extension at maximum load (64.9 ± 
9.5 mm and 52.4 ± 8.4 mm respectively), higher mean extension at failure (65.4 ± 
9.5 mm and 52.6 ± 8.5mm respectively), higher mean extension at maximum load 
(64.9 ± 9.5 mm and 52.4 ±8.4 mm respectively) and higher mean tensile stress at 
maximum load (43.13 ± 6.87 N/mm2 and 36.8 ± 9.1 N/mm2) (p<0.05) (Table 2-5). 
The results of the rest of the biaxial mechanical testing were not significantly 
different between the treatment groups (p>0.05) (Table 2-5, Figure 2-9). 
There was a significant correlation between the construct and method of failure (p 
< 0.05). Of constructs modified with clamps, 80% failed because the suture broke, 
and 20% failed because the cricothyroid ligament tore (Figure 2-7). Standard LTF 
constructs failed because the thyroid cartilage tore (80%) or because the 
cricothyroid ligament tore (20%).  
Discussion  
The mode of failure of the construct modified with laryngeal clamps differed from 
the mode of failure of the LTF construct. The mode of failure of the constructs 
correlated with the type of implant used, regardless of whether one side of the 
larynx or both sides of the larynx were tested. The LTF construct and the LTFB 
construct failed in uniaxial testing most commonly by pulling of the implant through 
the thyroid cartilage. Less commonly, the construct failed when the cricothyroid 
ligament tore. The LTF construct failed in biaxial testing when the suture pulled 
through the thyroid cartilage. The construct with the laryngeal clamps failed in 
uniaxial testing when the thyroid cartilage elevated and separated from the cricoid 
cartilage at the cricothyroid ligament. All constructs with the laryngeal clamps failed 
in biaxial testing when the suture broke close to one of the laryngeal clamps. The 
laryngeal clamps, therefore, protected the thyroid cartilage from tearing during 
uniaxial and biaxial testing.  
The mode of failure of the biaxial construct modified with clamps may have 




than polyester suture, had been used. Polyethylene suture has been shown to 
provide greater resistance to fraying, higher tensile strength, and more elasticity 
than the polyester suture used in both trials in our study (26,33). Although 
polyethylene sutures performed better than polyester sutures in another similar 
study, the difference in the performance of the entire construct was not statistically 
significant, because the failure of the construct was due to failure of the thyroid 
cartilage, rather than a failure of the suture (25). A study examining the mechanical 
properties of various suture materials found polyethylene sutures to have a 500-
fold greater resistance to fraying than polyester sutures (33). This makes 
polyethylene sutures particularly advantageous for attaching to metallic anchors or 
to absorbable anchor eyelets (32). Comparing the mechanical performance of 
various types of sutures used with the laryngeal clamp was beyond the scope of 
this study.  
The force required to disrupt the LTFC constructs was similar to that of the LTF 
and LTFB constructs in uniaxial mechanical testing. The differences in the 
properties of biological samples, including a difference in viscoelasticity, may 
explain the high variability of force required to disrupt the constructs within each 
group. In biaxial construct testing, however, the pullout force for the LTF constructs 
was greater than the pullout force for the LTFC constructs. The LTFB construct 
was not included in biaxial testing because it performed more poorly in the single-
side testing than the LTF construct. In a recent biomechanical study, LTF 
constructs had a higher pullout force in biaxial testing than did constructs modified 
with suture buttons, regardless of whether the suture was polyethylene or polyester 
(25).  
The types of constructs failed at different forces and displacement at yield, 
because of the different modes at which they failed. The yield point in the 
mechanical testing corresponded with the force and displacement at which the 
cartilage or the cricothyroid ligament started to fail. Interestingly, the extension at 
which the construct failed differed distinctly among the types of constructs. The 
force and displacement at yield was highest for the LTF construct in the uniaxial 
testing followed next by the LTFC construct and then by the LTFB construct. The 
load at yield was higher for the LTFC construct than for the LTF construct in the 
biaxial testing. The higher load at yield resulted in a greater displacement at yield 
for the LTFC construct than for the LTF construct but not significantly so. The yield 
point of the LTFC constructs was rarely observed, because the entire construct 
moved in the Instron machine until the suture failed, whereas the yield point of the 
LTF construct was easily observed, because the suture, rather than the entire 
construct, moved until the yield point of the construct was reached, which was that 
point at which the thyroid cartilage began to tear.  
The lower tensile force required to tear the cartilage in the LTF construct was 
related to the higher shear stress applied directly to the thyroid cartilage by the 




larger area of the thyroid cartilage. Yield points have not been reported in previous 
mechanical studies examining LTF constructs (25-27). The study performed by 
Santos et al. (2014) examined the force at 20- and 30-mm extensions (25). We 
found the yield point to be about 34 mm for the LTF construct and about 42 mm 
for the LTFC construct, but the wide standard deviation for the LTFC construct 
suggests that the yield point was not constant for all tested constructs. 
The stiffness of the LTFB construct was higher than that of the LTF and LTFC 
constructs in the single-side testing, causing the LTFB to construct to have the 
shortest extension when the suture broke. The LTF and LTFC constructs had a 
similar extension at failure in the uniaxial testing. The extension at failure for the 
LTFB construct, however, was higher than that reported by Santos et al. (2015), 
though the trend in their study was similar (25). The LTFC constructs were stiffer 
than the LTF constructs in biaxial testing, resulting in a lower extension when the 
suture broke. The results of our tests showed that the LTFC constructs were stiffer 
than the LTF constructs in the single-side testing and the biaxial testing, and 
therefore, more force was required to disrupt the construct modified with clamps. 
The higher stiffness of the LTF constructs modified with the laryngeal clamps is 
likely to be associated with less laryngeal displacement under in-vivo conditions.  
Clinical failure of the LTF construct is reported to occur most commonly during 
recovery from general anesthesia when the horse rapidly and forcefully extends 
its head (25). In our study, the constructs modified with the laryngeal clamps had 
a pullout force of approximately 5.5 times that estimated to occur during maximal 
head extension (25). The tensile stress at maximum load was significantly lower 
for the LTFC construct than for the LTF construct, but the tensile stress at yield 
was higher for the LTFC constructs than for the LTF constructs. This may suggest 
that the tensile strength of the LTFC construct was greater at the moment when 
the cartilage or cricothyroid ligament began to fail. In the majority of the LTFC 
constructs, the suture, rather than the cartilage or the ligament, failed, resulting in 
a short yield phase just before failure. The tensile stress applied to the constructs 
under in-vivo conditions is not known, and therefore, the minimal stress the 
constructs must withstand is not known.  
The focus of this study was to evaluate the biomechanical performance of the LTF 
construct modified with a novel laryngeal clamp and to compare it to currently used 
constructs. One of the concerns with the novel design of the laryngeal clamps is 
the tension applied to the sutures, which results in shear stress between the 
sutures and metallic clamps during cyclical loading. The design tried to address 
these concerns and apply modifications aimed at reducing the shear stress 
between the suture and implant. Future research should examine additional 
modifications to reduce the shear stress on the suture to improve the performance 
of the LTFC construct. Also, the use of different sutures, such as polyethylene 
sutures, to anchor the clamps should be examined. The limitation of this study was 




differences in mechanical properties between the constructs. Accounting for the 
difference in the mean values of maximum loads between the constructs and the 
standard deviations within the treatment groups, the study would necessitate 237 
samples per treatment group to achieve study power β>0.8. Furthermore, this is 
an ex-vivo study in which each of the larynges had to undergo one freeze-thaw 
cycle which could have influenced the mechanical performance of the thyroid 
cartilage or the cricothyroid ligament. The results of this study might differ from the 
physiologic conditions and should be therefore interpreted with caution. 
Conclusions  
The prototype of the laryngeal clamp may offer an alternative to suture anchoring 
in the thyroid cartilage in LTF constructs. The unique design of the laryngeal clamp 
protected the cartilage by reducing the shear stress of the suture applied to the 
cartilage, which resulted in the higher force and tensile strength at the failure of the 
cartilage or ligament. This was associated with the increase in stiffness of the 
construct. Increasing the stiffness of the construct could result in the lower 
displacement of the construct over time in-vivo. The increased stiffness of the 
construct modified with the clamps resulted in the sutures failing at lower maximum 









































Thickness measurements (mm) 
Position Mean Std. Deviation 
1.00 3.8872 .84690 
2.00 3.9444 .76652 
3.00 3.9336 .72256 
4.00 3.5096 .56269 
5.00 3.7696 .60627 
6.00 3.9156 .67555 
7.00 6.0163 1.22410 
8.00 4.9548 .81034 
9.00 4.4984 .67038 




Table 2-2. Thickness comparison between laminae of thyroid cartilage. 
Comparison of thickness between the left and right laminae of the thyroid cartilage. 
There were no significant differences between the left and right laminae at any of 
the measured positions.   
2-tailed independent samples T-test between left and right thyroid 
cartilage 
 
Measurement Side Mean Std. Deviation Sig. (2-tailed) 
Position_1 L 3.8872 .84690 .278 
R 4.1456 .81930 .278 
Position_2 L 3.9444 .76652 .372 
R 3.7652 .63383 .372 
Position_3 L 3.9336 .72256 .563 
R 4.0536 .73439 .563 
Position_4 L 3.5096 .56269 .332 
R 3.6696 .59214 .332 
Position_5 L 3.7696 .60627 .910 
R 3.7496 .64440 .910 
Position_6 L 3.9156 .67555 .791 
R 3.9692 .74584 .791 
Position_7 L 6.0163 1.22410 .716 
R 5.8872 1.23921 .716 
Position_8 L 4.9548 .81034 .856 
R 4.9972 .82942 .856 
Position_9 L 4.4984 .67038 .535 
R 4.6244 .75340 .535 
Position_10 L 6.4740 1.43194 .495 




Table 2-3. Side comparison in uniaxial testing.  
 
Comparison of average biomechanical results obtained during uniaxial testing 
involving the left or right laminae of the thyroid cartilage (2-tailed independent 
samples T-test). The data obtained from the left side of the larynges did not differ 
significantly from that obtained from the right side of the larynges.   
2-tailed independent samples T-test between left and right thyroid 
cartilage 
 




Average Thickness L 4.5833 .73626 .670 
R 4.6987 .73201  
Maximum Load (N) L 190.4900 34.96656 .614 
R 197.6793 41.82675  
Stiffness (N/mm) L 4.0580 1.40277 .884 
R 4.1240 1.03332  
Extension at Failure 
(mm) 
L 56.1173 17.44167 .627 
R 52.9907 17.37226  
Extension at Max Load 
(mm) 
L 55.7880 17.60501 .461 
R 51.1160 16.65160  
Extension at Yield 
(mm) 
L 38.8507 14.03225 .637 
R 41.1693 12.53842  
Load at Yield (N) L 151.7260 45.32798 .604 
R 159.9007 39.84170  
Tensile Stress at Yield 
(N/mm2) 
L 15.1747 4.53286 .605 
R 15.9900 3.98632  
Tensile Stress at Max 
Load (N/mm2) 
L 18.8954 3.20007 .535 








This table shows the mean values and standard deviations of the results of 
biomechanical testing of 3 constructs. The results differed significantly in maximum 
load (N) and load at yield (N) between the LTFC, LTF and LTFB constructs.  
ANOVA of three different constructs 
Variable Construct Mean Std. Deviation Sig. 
Maximum Load (N) LTF 199.0180 19.27660 .024 
LTFB 176.3040 43.18806  
LTFC 206.9320 43.21904  
Stiffness (N/mm) LTF 3.8600 .93406 .177 
LTFB 4.7650 1.36203  
LTFC 3.6480 1.10265  
Extension at 
Failure (mm) 
LTF 55.6220 12.66911 .087 
LTFB 46.2630 14.58875  
LTFC 61.7770 21.02075  
Extension at Max 
Load (mm) 
LTF 53.0860 11.89288 .125 
LTFB 45.9100 14.71806  
LTFC 61.3600 20.99364  
Extension at Yield 
(mm) 
LTF 46.0220 12.83827 .125 
LTFB 29.2360 8.72437  
LTFC 44.7720 10.95712  
Load at Yield (N) LTF 167.5140 23.34335 .003 
LTFB 138.5570 51.10873  
LTFC 161.3690 45.24054  
Tensile Stress at 
Yield (N/mm2) 
LTF 16.7520 2.33487 .278 
LTFB 13.8570 5.11180  
LTFC 16.1380 4.52568  
Tensile Stress at 
Max Load (N/mm2) 
LTF 19.8430 1.86375 .279 
LTFB 18.1510 4.24579  




Table 2-5. Comparison of biomechanical results during construct testing. 
 
 
The LTFC construct was inferior to the LTF construct in maximum load (p < 0.05), 
extension at failure (p < 0.05), extension at maximum load (p < 0.05), and tensile 
stress at maximum load (p < 0.05). The LTFC construct showed, however, a 
superior trend compared to the LTF construct in extension at yield (p < 0.05). The 
difference between the constructs in the remaining results were not significant 
(p>0.05).  
2-tailed independent samples T-test between two constructs 
 






LTF 4.6010 .33834 .500 
LTFC 4.7880 .79014  
Maximum Load (N) LTF 430.2940 64.84309 .032 
LTFC 367.8790 55.19138  
Extension at Failure 
(mm) 
LTF 65.3910 9.47112 .005 
LTFC 52.5820 8.49355  
Extension at Max 
Load (mm) 
LTF 64.8970 9.52261 .006 
LTFC 52.4210 8.44992  
Extension at Yield 
(mm) 
LTF 33.3780 8.98399 .026 
LTFC 42.5410 7.81333  
Load at Yield (N) LTF 264.6490 65.42587 .257 
LTFC 306.2130 91.09641  
Tensile Stress at 
Max Load (N/mm2) 
LTF 43.1300 6.86934 .040 
LTFC 36.8210 9.10953  
Tensile Stress at 
Yield (N/mm2) 
LTF 26.4660 6.54315 .257 
LTFC 30.6210 5.51279  
Stiffness (N/mm) LTF 6.7250 1.12806 .640 









Figure 2-1. Thickness at 10 different anatomical positions.  
The thickest portion of the thyroid cartilage was found in positions 7-10, at the 




Figure 2-2. Single-side LTF mechanical testing.  
This figure presents the experimental arrangement of a larynx in the MTS testing 
machine. The larynx was attached to the 3.2-cm PVC cylinder, which was attached 
to the holding grip of the MTS machine. A custom-made holding grip with a 
stainless-steel bar was attached to the loading cell. Each larynx was in the same 
treatment group, but each side of the construct was tested separately. The ends 




Figure 2-3. Biomechanical constructs testing.   
This figure shows the arrangement of the LTF and LTFC constructs in the MTS 
machine. Larynges were mounted on a PVC cylinder, as in the single-side testing, 
and the basihyoid bone was attached to the holding grip of the loading cell. In the 
standard LTF construct, on the left side, the free ends of the ipsilateral dorsal 
suture and contralateral ventral suture were advanced rostrally and dorsally to the 
basihyoid bone. The same procedure was performed on the right side. The ventral 
and dorsal sutures were tightened and tied together around the ventral aspect of 
the lingual process of the basihyoid bone. In the LTF construct modified with the 
laryngeal clamps, both ends of the sutures were advanced rostrally and dorsal to 








Figure 2-4. Suture Button.  
The commercially available suture button used for this study was a part of the kit 
for the human cruciate ligament repair. The surgical technique used to anchor the 
















Figure 2-5. Views on laryngeal clamps.  
The design of laryngeal clamps aimed at creating an anchor that wrapped around 
the caudal border of the thyroid cartilage to distribute the tensile forces applied to 
the suture. The laryngeal clamps were U-shaped, 5 mm wide, and 1cm long. The 
short arm was placed on the dorsal surface of the thyroid cartilage, and the long 
arm was placed on the ventral surface of the cartilage. The part connecting the 
bottom and top parts was responsible for distributing the tensile force. The short, 
dorsal arm had two holes, creating an eyelet for the suture, and the longer ventral 




Figure 2-6. Laryngeal clamps on the thyroid cartilage.  
The figure shows the arrangement of the laryngeal clamp around the caudoventral 
border of the thyroid cartilage. The dorsal arm had an eyelet with the relief between 
two holes, through which the suture was threaded before the clamp was placed. 
The ends of the suture were threaded through the eye of a ½-circle needle, which 
was passed through the caudal margin of the thyroid cartilage. After the needle 
was passed, the ends of the suture were threaded through the slit on the dorsal 
arm of the clamp. Tension applied to the suture caused the clamp to engage the 
caudal margin of the lamina of the thyroid cartilage. The suture of this construct 
had no dorsal and ventral arms, because both arms were inserted through the one 





Figure 2-7. Before and after constructs testing.  
The image on the left shows the construct before the testing, and the image on the 
right shows the construct after the testing. The left and right laminae of the thyroid 
cartilage are labeled. Notice that the appearance of the thyroid cartilage on the 
right looks similar the appearance of the thyroid cartilage before the test. In this 
case, the right laryngeal clamp pulled out from the thyroid cartilage without 
inducing severe disruption of the crico-thyroid ligament and alteration of the 




Figure 2-8. Comparison of biomechanical performance of uniaxial 
constructs.  
The uniaxial LTFC construct (gray line) attained the highest maximum load 
followed first by the LTF and then LTFB construct. The method of failure 
associated with LTFC construct was tearing of the cricothyroid ligament, whereas 
the LTF and LTFB constructs failed because the thyroid cartilage tore. The LTFC 












Figure 2-9. Comparison of biomechanical performance of the constructs. 
The yield point of the LTF construct corresponded to the moment at which the 
construct started to tear the thyroid cartilage. The first peak in this graph represents 
tearing of the thyroid cartilage, and the second peak represents tearing of the 
cricothyroid ligament. The LTFC construct failed when the suture failed its 
attachment to the laryngeal clamp; no damage to thyroid cartilage was noticed at 
the point of failure. The laryngeal clamp provided higher stiffness, force, and tensile 
stress at yield point and a different method of failure, which was significantly 













IDDSP – Intermittent Displacement of the Soft Palate  
LTF – Laryngeal Tie-forward 
LTFB – Laryngeal Tie-forward modified with suture buttons  
LTFC – Laryngeal Tie-forward modified with laryngeal clamps  
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CHAPTER THREE  
BIOMECHANICAL EVALUATION OF PEAK REVERSE TORQUE 
(PRT) IN A DYNAMIC COMPRESSION PLATE - SCREW 
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The strength of the bone and implant interface has been significantly correlated 
with the primary and secondary stability of the implant. Primary stability is achieved 
by the implant immediately after placement and it leads ultimately to secondary 
stability, through the osseointegration process. Osseointegration has been found 
to be influenced by several factors, from which the most important are loading 
conditions applied to the implant and associated micromotion. The loading 
stresses are not evenly distributed between the screws placed in orthopedic plate 
and plate axial stability has been attributed to the stability of the weakest screw. 
The purpose of the conducted in-vivo study was to evaluate the osseointegration 
of the screws placed in dynamic compression plate (DCP) in tibial segmental 
defects in goats. Further objective included the comparison of osseointegration 




Peak reverse torque (PRT) is a valid method to evaluate implants’ secondary 
stability in the healing bone. The secondary stability is achieved by the implant 
over time and it has been positively correlated with the implants’ osseointegration 
level. In other words, peak reverse torque is the force required to break the bone-
implant interface. The purpose of this study was to compare the peak reverse 
torque for the self-tapping and non-self-tapping screws used in a dynamic 
compression plate–screw–bone construct after 60 days of loading when used to 
stabilize 2.5-cm defects in the tibia of goats. The second objective was to compare 
the peak removal torque of the screws placed in the different positions to evaluate 
the impact of construct biomechanics on implants osseointegration.   
Results 
In total, 176 non-self-tapping screws and 66 self-tapping screws were used to fix 
the 8-holes dynamic compression plates to the bones. The screws were placed in 
the tibiae from proximal (position sites 1,2, 3) to distal (position sites 4,5,6) and 
were removed 60 days post-implantation. The goats remained weight-bearing 
throughout the study period. The screws placed in the proximal diaphysis had 
significantly less peak reverse torque than screws placed in the distal diaphysis in 
both groups (p < 0.05). The peak reverse torque resistance was also significantly 
less for the non-self-tapping screws as compared with the self-tapping screws (p 
< 0.05). The intracortical fractures in the trans-cortex occurred significantly more 
frequently during the placement of non-self-tapping screws (p < 0.05) as compared 
with self-tapping screws (p < 0.05).  
Conclusions 
Based on these results, we concluded that self-tapping screws may be expected 
to maintain a more stable bone-implant interface during the first 60 days of loading 




orthopedic surgeons and scientists using bone plates to stabilize non-load sharing 
fractures when a stable plate-screw-bone interface is needed to ensure prolonged 
stability.  
Introduction 
Maintenance of the interface between screws and bone is important to ensure 
adequate stabilization of fractures and to maintain mechanical support for the 
healing tissue (1,2). The screw is a critical linkage to secure bone plates to bone. 
Assuming that, the plate is sufficiently stiff and resilient under cyclical loading 
conditions, and then the integrity of the screw-bone interface determines the 
overall stability of the construct. The bone-screw interface is defined by its primary 
and secondary stability. Primary stability is obtained by the screw immediately after 
placing it into the bone and has been associated with several factors: surgical 
technique, implant design, surface properties, loading, and quality of the bone (1,3-
6). Secondary stability refers to the long-term stability of the screw-bone interface 
and is directly related to the osseointegration between the bone and the implant’s 
surface (3,7). Several factors have been described to be of importance in this 
process: biocompatibility, surface texture, surgical technique, the status of the host 
tissue, and loading conditions (3,7). Secondary stability can be measured using 
resonance frequency (RF) or peak reverse torque (PRT) (3,8). Several studies, 
mostly on orthodontic implants, have used PRT (3-7,9-15) showing that peak 
reverse torque has been positively correlated with the osseointegration process 
(3,5-6,13-16) and bone density (3,6,11,14). 
Various fixation techniques have been described and used to stabilize tibia defects 
using large animal models (17-21). These techniques include a single dynamic 
compression plate fixation (17-19), locking intramedullary nail (20), and double 
plate fixation (21) resulting in the different mechanical environments for the 
regenerating bone. The studies that have used a single DCP concluded that this 
fixation technique provides adequate stabilization for most large animal tibia defect 
models (17-19).  
Dynamic Compression Plate (DCP) is a type of conventional plate commonly used 
in the fracture repairs (22). The plate mechanics rely on a transfer of the axial 
loading forces from the bone to the proximal screws, which transfer the load into 
the plate; this load is then transferred from the plate back to the distal bone 
segment via the distal screws. Ground reaction forces are controlled in the same 
manner but in a reverse direction. The resulting shear (frictional) forces across the 
plate-bone interface concentrate stress at the plate-screw-bone unit (2,22). The 
plate-screw-bone unit exerts shear forces along the bone-screw thread interface 
as a result of the torque applied to the screws during insertion when fixing the plate 
to the bone (approximately 3–5 Nm for 3.5 mm cortical screws placed into human 
femur) (23,24). The mechanical stability of the plate is affected by how well it is 
fitted against the surface of the bone (2). With the use of DCP, as the screw is 




hole, converting the descending movement of the screw into a gliding movement 
of the plate (2). Therefore, during the implant placement, the screw torque 
generates relative compressional strain on the bone surface and tension in the 
cortical bone around the screw threads (2). Each screw in this construct is loaded 
individually at the screw-bone interface and the farthest screws at each end of the 
plate tend to experience the largest interface loads (25).  
Although the entire construct can be tested via compression, bending, and torsion 
of the plate-screw-bone construct, those tests do not assess individually the 
integrity of each screw-bone interface. Peak reversal torque is a valid method to 
evaluate the implants interface as an indicator of osseointegration. 
Osseointegration has been positively correlated with the loading conditions around 
the implant. The axial strength of the plate may be predicated on the axial strength 
of the weakest screw in the plate-screw-bone construct because this weakening 
results in transference of loading forces to adjacent screws. The evaluation of each 
screws' osseointegration provides insight into this aspect of the plate-screw-bone 
construct stability. Although the PRT of the various screws has been studied, to 
our knowledge, studies on reverse torques of screws used in plate-screw-bone 
constructs after periods of loading are lacking.  
The objectives of this study were to measure the peak reverse torque (PRT) of 
each screw used in a plate-screw-bone construct at the time of its removal after 
60 days of in-vivo loading in a non-load sharing, 2.5 cm segmental defect in goats. 
We hypothesized that the PRT would vary among the screw positions as a result 
of the cyclical loading construct biomechanics. Secondly, we hypothesized that the 
ST screws used to fix the plate would have superior PRT compared with that of 
NST screws after 60 days of cyclical loading.  
Materials and Methods 
Animal study: The goats in the study were participating in a research project 
studying bone healing of a non-load sharing, mid-diaphysis segmental defect (2.5-
cm length) of the tibia under an approved protocol (KSU IACUC # 2947) (Figure 3-
1, all figures and tables are placed in the appendix). The goats participating in the 
study were mix bred adult (>2 years old) female goats weighing 35 to 65 kgs 
purchased from the local vendors for the research purpose and owned by the 
university. The goats were healthy and without evidence of lameness or bone 
abnormalities. Briefly, the defect creation procedure was performed under general 
anesthesia which was maintained with the Isofluranea gas inhalant (2.5% - 4% 
MAC at the beginning of anesthesia and 1.5% MAC – 1.0% MAC during the 
procedure). The goats were sedated with 0.05 mg/kg, IV Xylazineb (20 mg/ml) and 
induced with 5mg/kg IV Ketaminec (100 mg/ml) and 0.25 mg/kg IV Midazolamd (5 
mg/ml). During the defect creation procedure an 8 - hole 4.5 mm 316L stainless 
steel DCPe and 3.5 mm 316L stainless steel cortical bone screwse were used to 
stabilize the bone. Each bone segment (proximal, distal) received 3 screws. For 




positions 1, 2 and 3 from proximal to distal. Screws placed in the distal bone 
segment were assigned positions 4, 5 and 6 from proximal to distal. Goats were 
monitored for lameness daily during the study periods to assess the use of the 
operated limb. 
 
In each goat, the DCP were fixed with only one type of screw, either NST cortical 
screws or ST cortical screws. All the screws used for this study were placed in 
standard AO/ASIF fashion and all were bi-cortical screws (near and far cortex). 
Briefly, the thread hole (2.4 mm diameter) was drilled with 12 V battery operated 
performance drillf (maximum torque 19.21 Nm) and in the NST screws group it was 
tapped manually prior to the screw placement. Both screw types (NST and ST) 
were placed manually, using a handheld screwdriver. The screw lengths ranged 
between 18 mm to 24 mm, the core diameter equaled 2.4 mm, the thread diameter 
equaled 3.5 mm, and the thread pitch equaled 1.25 mm. The screws were inserted 
by three of the surgeons (DEA, JR, and JL) and the method was uniformly used 
by all surgeons. It has been recommended that the tapered tip and cutting flutes 
extend beyond the far cortex, therefore a care was taken that at least 3 threads of 
the screw were anchored in the far cortex to maintain rigid fixation (35). All DC 
plates were fixed with 6 screws in total; 3 proximal to the osteotomy and 3 distal to 
the osteotomy (Figure 3-1). The screws remained in place for 60 days (40) and 
were removed at the termination of the study period. Radiographic images were 
obtained for all goats on days 7, 14, 30, and 60 of the study periods, and they were 
evaluated to document the occurrence of transcortical diaphyseal tibial fractures 
in the cortices evident on radiographs and any change in screw-plate-bone 
interface, position, and fracture gap.  
After 60 days of the study period the goats were euthanized with overdose of 
pentobarbital administered intravenously. Euthanasia was induced by rapid 
intravenous injection into the jugular vein using pentobarbital (100 mg/kg body 
weight, IV) in accordance with the AVMA guidelines on the euthanasia of goats 
(41). Pentobarbital rapidly induces unconsciousness without excitation. Death was 
confirmed by cessation of any detectable heartbeat and breathing, and loss of 
corneal reflexes. All implants were removed in the same manner, starting from the 
most proximal position (1) and following the order (from 1 to 6) until the most distal 
screw (6). The plate was stabilized manually and therefore prevented from its 
movement during implant removal. The peak reverse torque for each screw was 
measured using a handheld torque driverg. The pressure was applied gradually 
increasing, until the screw turned and then stopped. The torque driver did not 
require calibration and zeroing prior to the test. The handheld torque driver 
measured torque in the range between 0 – 22.6 Nm. After the implants had been 
removed and the tissues had been harvested for histopathology within the study 





Data was analyzed using a mixed-effects multinomial logistic regression model 
with the reverse torque categories as the multinomial outcome variable and the 
screw type (non-self-tapping and self-tapping) as well as screw position in the plate 
(proximal to distal with the increasing numbers from 1 to 6) as the fixed 
independent effects (multinomial exposure variable). The Odds Ratios, as well as 
95 % Confidence Intervals (95% CI) for fixed effects (screw type and screw 
position), were estimated with the reference to the screw position no. 6 and self-
tapping screw type while holding other effects constant. Statistical significance was 
identified at the level of p < 0.05.  The statistical analysis of the association 
between the transcortical diaphyseal tibial fractures and the screw type as well the 
fractures and PRT was done using two-sided Fisher’s exact test. Statistical 
Analysis was performed using PROC GLIMMIX in SAS9.4 TS1M4 for Windows 
64xh.  
Results 
All goats remained weight-bearing throughout the study period. A total of 318 
screws were used for the study, of which the PRT data for 76 screws were not 
included in the PRT study due to the following factors: large callous formation 
around the plate and screw heads (3 plates), plate bending (4 plates), goat removal 
from the study prior to 60 days (3 plates) and device reading errors (16 screws). 
The plate bending observed in 4 constructs occurred in goats which showed 
subjectively evaluated higher level of activity as compared to the other goats. 
There was no relationship between the weight of the goat and bending of the 
construct. The remaining 3 goats were removed from the study approximately 1 
month after the procedure due to the pullout and displacement of the three most 
proximal screws resulting in the plate displacement more than 1 cm away from the 
tibia. The peak reverse torques of 242 screws were included in this study, of which 
176 were NST screws and 66 were ST screws (Table 3-1).  
Based on evaluation of the initial results of the PRT measurements, PRT data was 
categorized into four reverse torque ranges: low (t = 0 Nm), medium (0 Nm< t 
<0.66 Nm), high (0.66 Nm< t <2.60 Nm) and maximal PRT (t > 2.60 Nm). After 60 
days of loading, 9.09% of all NST screws, as well as 4.55 % of all ST screws, were 
placed in the low PRT category (t = 0 Nm). The 38 ST screws and 44 NST screws 
(58% of all ST screws and 25% of all NST screws respectively) exceeded 22.6 
Nm, the maximum range of the torque driver.  
The two-sided Fisher’s Exact Test revealed that the transcortical diaphyseal tibial 
fractures occurred significantly more frequently in the NST screws group (p < 0.05). 
The fractures however did not influence the PRT after 60 days (p > 0.05). During 
the placement of the screws, the transcortical diaphyseal tibial fractures occurred 
in 37 NST screws and in 5 ST screws (21% of all NST screws and 8% of all ST 
screws, respectively). The transcortical fractures were most often observed in the 
screw position no. 4 and no. 5 (41.4% and 31.03% of all transcortical fractures in 




ST screws where the fractures were equally distributed between each position, 
from 1 through 5 (20% of all fractures in each position in ST screw group) (Table 
3-2). 
Statistical analysis revealed significant differences between the NST screw PRT 
and the ST screw PRT (p <0.05). NST screws were significantly more likely to 
result in PRT less than 0.66 Nm (Table 3-1). ST screws were significantly more 
likely to have PRT greater than 0.66 Nm (Table 3-1). Significant differences in PRT 
were found based on the screw insertion position. Screws placed in the proximal 
tibia (positions 1, 2, and 3) had significantly lower PRT as compared with those 
placed in the distal tibiae (position 4, 5, and 6) (Table 3-1). The relationship of 
screw position and PRT was similar among ST and NST screws (Table 3-1).  
Discussion 
To our knowledge, measurement of PRT has not been reported after a sustained 
period of loading in-vivo. The model used herein is a non-load sharing model 
resulting in significant cyclical forces being applied to the bone-screw-plate 
construct and especially at the bone-screw interface. Similar to previous studies, 
the DCP provided adequate fixation with satisfactory stability for the non-load 
sharing tibia defect during this 60-day period of study (17-19). 
Screws placed proximal to the ostectomy tended to exhibit lower PRT than the 
screws placed distal to it. Lower torsional forces needed to break the bone-implant 
interface have been related to less implant osseointegration (3,5-6,13-16). There 
are several factors which are of importance in the osseointegration process: 
biocompatibility, surface quality, surgical technique, the status of the host tissue, 
and loading conditions (3,7). In the DCP-screw-bone construct, the screws on each 
end of the plate tend to be exposed to higher loads (2,22) and this has been 
negatively associated with implant osseointegration (3,7). Bottland et al showed 
that screws placed remotely to the fracture or osteotomy sustain greater loads than 
the screws adjacent to the fracture (26). The reduced exposure to mechanical 
forces may allow for improved osseointegration resulting in greater extraction 
torques (26). Repeated loading delays bone on-growth around the implant 
lessening osseointegration (1,11,26). In this study, proximal screws exhibited 
lower PRT which was most likely due to higher absorption of repeated load than 
the distal screws. This phenomenon was less clearly observed in the ST screw 
group. This may be related to the already proven increased insertional torque and 
primary stability of the ST screws (27-31). PRT has been shown to have a positive 
correlation to the surrounding bone quality (3,6,11). Several studies have shown 
that the tibiae have lower BMD in the proximal-mid part of the bone and greater in 
the distal portion (32-34). The goats used for our study were adult, healthy, and 
free of lameness or pathologic bone condition. Thus, we would expect that BMD 




ST screws exhibited greater peak reverse torques (PRT) than NST screws after a 
period of 60 days of loading in a screw-plate-bone construct. The ST screw threads 
placed into the bone are expected to more closely contact the bone surface with 
compression as compared with NST screws due to the lack of the tapping process 
prior to the screw placement (1,35). The tap device designed for use with NST 
screws has been shown to have longer threads than the screws and this 
discrepancy creates a micro space between the screw thread and cut bone (35). 
This incongruity can result in implant micromotion (35) which can reduce the 
primary stability of the screws. Several studies have shown that the ST screws 
exhibit greater peak insertional torque (PIT) than the NST screws (1,5,16,36). 
According to these studies, ST screws obtain greater primary stability than the NST 
screws (3) and show better interfacial stiffness at the implant-bone interface (4). 
Micromotion causes filling of the space between the bone and the implant with 
fibrous tissue or encapsulation of the implant (5). Moreover, this process can lead 
to excessive bone resorption and inflammation around the implant (peri-implantitis) 
(4,5,35). These processes will result in reduced implant secondary stability which 
will negatively influence the longevity of the implant as reflected by decreased 
PRT. In contrast, the ST screws due to their greater insertional stress have been 
associated with increased incidence of bone damage promoting bone failure (1) 
and transcortical diaphyseal tibial fractures (35). These incidences may reduce 
primary as well as secondary stability. In contrast, the number of transcortical 
diaphyseal tibial fractures in our study was greater within the NST screws than in 
ST screws.  
The length of the NST and ST screws ranged between 18 and 24 mm in our study 
and all of the screws were placed bicortical. Previous research on a different length 
of the orthodontic implants (1.4 – 3.8 mm) did not show any significant correlation 
between the length of the implant and PRT as long as the implant was longer than 
1.4 mm, which was considered as implants’ minimal length (37). The minimal 
length of the cortical screw is considered when at least 3 threads of the implant 
can be placed through the far cortex in order to achieve the rigid fixation (1). In this 
study in all cases at least 3 threads of the screw were anchored in the far cortex.  
The mean PRT of ST and NST screws in this study are comparable with the 
previous studies on PRT of screw implants. PRT values vary between studies due 
to factors affecting the osseointegration process and different materials used for 
the biomechanical tests (3,14,38).  
Reverse torque can be a valid method to assess the biomechanical properties of 
orthodontic implants. This method has been used to reach a better understanding 
of the osseointegration process (3-7,10-16). The term ‘integration strength’ refers 
to the force required to break the bond between the implant and the bone, and this 
can be measured with the PRT (4). Okazaki et al. showed that insertional torque 
positively influenced PRT immediately after implant placement. However, the PRT 
decreased with healing time and showed no difference between the screws at 




time but may increase again as remodeling of the surrounding bone takes place 
(5). Histological examination of the bone healing process around titanium implants 
has shown that the existing bone initially resorbs at the bone-implant surface and 
is replaced by newly formed bone (5). The screws in our study were used in a non-
load sharing segmental defect of the tibiae model in goats for approximately 8 
weeks resulting in varied reverse torques between ST and NST screws. Some 
investigators have observed a positive correlation between the bone-implant 
contact (BIC) and PRT (13,15) while others claimed that the bone quality formed 
around the implant is more important than the amount (3,6,11,14).  
 
The main limitation of this study is the lack of measured peak insertional torque 
(PIT) during the screw placement. Even though the PIT defines implants primary 
stability (1,26,39) not their secondary stability (3) which was measured in this 
study, it could have been used to standardize the screw placement within the plate. 
In this study however, limitations of equipment and study design prevented 
measurement of insertion torque, therefore the variability of insertion torque may 
have contributed to differences in PRT. Next, the torque unit was limited in a range 
which resulted in the inability to measure low and high range torques. The torque 
cell had been selected based on expectations derived from previous studies. 
Finally, hence this in-vivo study was a part of another research project, introducing 
the control group was not possible. The control group would have consisted of the 
screws on which the primary stability would have been measured. The screws 
would have been placed in the same fashion as described above and they would 
have been removed immediately after their placement. The PRT would have been 
measured right before the implant removal. These are the weaknesses that may 
be addressed in future work.   
Conclusions 
The DCP-screw-bone construct is an adequate fixation method providing a 
sufficient stabilization in this 2.5 cm tibial defect model. The construct stabilization 
can be assessed by measuring implants osseointegration. The ST screws were 
shown to have a stronger bone-implant interface based on better PRT as 
compared with NST screws after 60 days post-implantation. Screws placed in the 
proximal tibia exhibited significantly lower peak reverse torque than those placed 
in the distal tibia. The lower reverse torque in the proximal tibia may be influenced 
by load distribution in the goats’ tibiae-plate assembly or because of different bone 
density between the proximal and distal parts of the bone. This phenomenon was 
less evident in the self-tapping screws presumably because of the greater primary 








Table 3-1. Peak Reverse Torque categories for NST and ST screws. 
 
 
Most of the NST screws PRT were categorized as High and Medium, whereas the 
ST screws PRT were mostly categorized as Maximal and High. Overall screws in 
the position 1-3 were categorized as Medium and Low, whereas the distal screws 
in positions 4-6 in the majority were categorized as Maximal and High in both screw 
types (ST and NST). The last line of the table presents the percentage of overall 












Peak Reverse Torque Groups 




Max High Med Low Total Max High Med Low Total 
1 5 8 13 4 30 3 3 3 2 11 
2 5 13 9 2 29 4 4 3 0 11 
3 4 2 14 9 29 5 4 2 0 11 
4 9 12 8 0 29 9 1 0 1 11 
5 16 8 5 0 29 9 2 0 0 11 
6 9 11 9 1 30 8 3 0 0 11 
Total 48 54 58 16 176 38 17 8 3 66 
% of 
total 




Table 3-2. Prevalence of cortical fractures within each screw type. 
 
 
The intracortical fractures occurred in the trans cortex more frequently during the 
placement of the non-self-tapping screws (37) as compared with the self-tapping 
screws (5). The position most commonly associated with the fractures were 
position no. 4 and position no. 5 in the NST screws group. In the ST screws group 
the fractures were more equally distributed between the positions.  
Screw Type 


















1 30 2 6.7 11 1 9.1 
2 29 6 20.7 11 1 9.1 
3 29 5 17.2 11 1 9.1 
4 29 12 41.4 11 1 9.1 
5 29 9 31.0 11 1 9.1 





Figure 3-1. Goat tibial defect ostectomy. 
Goat tibial ostectomy model supported with an 8 – hole dynamic compression plate 
(DCP). The 2.5 cm defect was created in the mid-tibia and the plate was fixed with 
6 ST or NST screws placed proximally to the ostectomy (pos. 1 – 3) and distally 









BMD – Bone Mineral Density 
BIC – Bone Implant Contact 
DCP – Dynamic Compression Plate 
IV – Intravenous 
MAC – Minimal alveolar concentration 
NST – Non-self-tapping  
PRT – Peak Reverse Torque 
PIT – Peak Insertional Torque 
RF – Resonance Frequency 



































a. Isoflurane, Abbott Laboratories Inc., 100 Abbott Park Road, Abbott Park, 
IL60064, USA 
b. AnaSed, Lloyd Laboratories Inc., #10 Lloyd Avenue, First Bulacan 
Industrial City Brgy Tikay, City of Malolos, Bulacan, Philippines  
c. Ketamine, Pfizer Inc., 235 East 42nd Street NY, NY 10017, USA 
d. Midazolam, AmerisourceBergen Inc., 1300 Morris Drive, Chesterbrook, 
PA 19087, USA 
e. Dynamic Compression Plate, Self-tapping and Non-self-tapping screws, 
DePuy Synthes Inc., 325 Paramount Dr. Raynham, MA 02767, USA 
f. Performax 12 V 3/8” cordless drill, 5101 Menard Drive, Eau Claire, WI 
54703, USA  
g. Electrotorque System TQJE1500, Snap-on Inc, 2801 80th Streer 
Kenosha, WI 53143, USA 
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CHAPTER FOUR  
ASSESSMENT OF A 3D HYDROPHILIC POLYURETHANE 
SCAFFOLD CONTAINING NANO-HA AND BONE PARTICLES, 
WITH OR WITHOUT BMP2 OR MESENCHYMAL STEM CELLS, 
ON BONE REGENERATION AND NEOVASCULARIZATION OF 



















Large segmental bone defects (>5cm) result from a traumatic injury and are often 
associated with extremity amputation. This research provides a valuable 
alternative to restore such defects with novel nano-based bone scaffolds (PU-nHA-
DBP). 61 female and mature goats were included in this study. The goats were 
randomly assigned to 4 treatment groups with average of n=8, including control, 
bone scaffold only, bone scaffold soaked in rhBMP-2 and bone scaffold coated 
with cMSC (n=7) as well as to 2 different study time points, including 2 months 
(n=31) and 6 months (n=30). Bone healing was evaluated using HD IR 
Thermography, Radiography, Dual X-ray Absorptiometry (DXA), Dual-phase 
quantitative Computed Tomography – Angiography as well as Histology. 
Peripheral blood was collected for the VEGF and BMP-2 measurements.   
Results 
The results of the bone healing assessment methods revealed significantly more 
dynamic bone regeneration within the bone scaffold with the cMSC treatment 
group. The defect healing within the bone scaffold rhBMP-2 and bone scaffold 
were comparable and significantly higher when compared to the controls. Neither 
the bone scaffolds nor the bioactive agents significantly stimulated the 
macroscopic neovascularization process. The peripheral blood BMP-2 
concentration increased in a linear manner in all treatment groups and the highest 
increase was observed in the scaffold rhBMP-2 group.   
Conclusions 
The bone scaffolds showed promising results in the restoration of large segmental 
tibial defects (>5 cm) in a goat animal model. None of the implants presented 
adverse defects in the body associated with implant rejection.  
Introduction 
The injuries of the musculoskeletal system are a significant problem in human 
orthopedics. Although the bone has extremely high potential to regenerate itself 
after damage (1-3) the efficacious repair of large bone defects resulting from 
resections, traumas, large defects or non-union fractures still requires the 
implantation of bone grafts (4-5). To date, the optimal bone grafts include the grafts 
from autologous bone harvested from the donor site of the individual. The 
significant disadvantage of those grafts is however associated with the increase of 
morbidity after the implantation and with the necessity of a second surgery (6). 
Therefore, the orthopedic research seeks to create the synthetic allografts which 
would reduce the morbidity and eliminate the requirement for additional surgery. 
The three-dimensional porous bone scaffolds with interconnected channels aim to 
provide an appropriate base for tissue growth and cell proliferation (7) as well as 





An ideal bone scaffold should have enough porosity to accommodate osteoblasts 
or osteoprogenitor cells, to support cell proliferation and differentiation, and to 
enhance bone tissue formation (9). The early cellular ingrowth, as well as rapid 
microvascular network formation, has been found to be optimal in the implants with 
the pore size ranging from 50 to 300 µm diameter (9-11). The larger channels of 
500 to 800 µm diameter support ingrowth or larger vessels which directly influence 
the bone regeneration (9-11). The neovascularization is one of the most important 
processes in the newly regenerated bone, as it provides oxygen and nutrients to 
the regenerating bone tissue (12-16). The process occurs most dynamically during 
the early stages of bone healing (14). The aim of the synthetic biomaterials is to 
enhance the bone healing and a variety of them have been tested. Polyurethanes 
are frequently employed in the biomaterials due to mechanical and biological 
advantages and recently they have gained interest as the platform used for the 
bone scaffolds (11,17-24). Furthermore, depending on the synthesis method the 
porosity in the material can be controlled in a feasible way (11).    
 
This study utilizes a novel technology bone scaffold technology that consists of the 
unique combination of three-dimensional and completely resorbable polyurethane 
platform (PU) coated with a nanophase Hydroxyapatite (nHA) and decellularized 
bone particles (DBPs) (25,26). The pore size varied between 50 and 800 m. The 
scaffold technology utilized in this research differs from those utilized in previous 
reports on polyurethane implants coated with nano-Hydroxyapatite in patented 
manufacturing methods as well as in the polyurethane platform (25-30). The novel 
technology implants are evaluated in the large animal (goat) model with a large 
(>5 cm) full-thickness segmental tibial defect. The study evaluates implants' 
influence on the neovascularization process during a short postoperative period 
and within the newly formed bone throughout the healing process.   
 
The first objective of this study (O1) was to assess scaffolds bone regenerative 
properties, specifically its ability to enhance the neovascularization process within 
2 and 6 months after the surgery. The bone scaffold was compared to the bone 
void (negative control) as well as to the scaffold coated with the recombinant 
human bone morphogenetic protein-2 (BMP-2) and scaffold seeded with caprine 
mesenchymal stem cells (cMSC). Both bioactive agents have been already proven 
to have a positive influence on bone regeneration, and BMP-2 furthermore has 
been described to mediate proangiogenic effects (31-34). The second objective of 
this study (O2) was to evaluate the recombinant human bone morphogenetic 
protein – 2 (rhBMP-2) and caprine mesenchymal stem cells (cMSC) influence on 
the bone regeneration and neovascularization process. The third objective (O3) 
was to evaluate the vascular endothelial growth factor (VEGF) and bone 
morphogenetic protein-2 (BMP-2) concentration within the peripheral blood. The 
first hypothesis (H1) was that the bone scaffold will be osteoinductive, 




regeneration of the large tibial defect. The second hypothesis (H2) was that it will 
further enhance the early neovascularization process. The third (H3) and fourth 
hypothesis (H4) were that the bone regeneration and neovascularization will be 
different between the treatment groups including scaffolds, scaffolds coated with 
BMP-2 and scaffolds seeded with cMSC. The fifth hypothesis (H5) was that there 
will be a difference in the peripheral blood VEGF and BMP-2 concentration 
between the treatment groups depending on the pace of bone regeneration. The 
bone regeneration was defined by tissue ingrowth and on growth caused by 
implants osteoinductive, osteoconductive and osseointegrative properties (35).  
Materials and Methods 
Study Population 
The study included 61 mix-bred adult (>2 years old) female goats weighing 
between 35 and 65 kgs. The goats underwent a routine screening process before 
the acquisition which consisted of general clinical health assessment and 
orthopedic evaluation. Any goat which showed clinical signs of a chronic disease, 
bad body condition score (1-2/5), signs of lameness due to an underlying disease 
or was positive for pregnancy screening was not included in the study. The length 
of the right tibiae varied between 22 and 25 cm. 61 goats were included in the 
study and randomly assigned to 4 treatment groups (n=7-8 goats per group) and 
2 study termination time points. The treatment groups involved negative control 
with the bone defect left unfilled, and the scaffold containing treatment groups, 
including bone scaffold, bone scaffold coated with e-coli derived recombinant 
human bone morphogenetic protein – 2 (rhBMP-2)a and bone scaffold seeded with 
the bone marrow-derived caprine mesenchymal stem cells (cMSC). The goats 
were humanely sacrificed at 2 study termination time points, including 60 days after 
the surgery and 180 days after the surgery. The study was performed under a 
protocol that was approved by the University of Tennessee Institutional Animal 
Care and Use Committee under protocol number 2606-0518.     
Nano-HA polyurethane scaffold preparation 
The nano-HA polyurethane scaffolds with demineralized bone particles were 
prepared as previously described (25,26). Each of the Nano-scaffolds assigned to 
the rhBMP-2a treatment group was soaked in 2 mg of rhBMP-2a (1mg/ml) 15 
minutes before implantation into the defect. The rhBMP-2a was applied on the 
scaffold surface during the surgery by the surgeon in sterile manner. Each of the 
bone scaffolds assigned to the cMSC treatment group was sterilely loaded with the 
low passage (P2-4) 5 x 106 cMSC/cm diameter 24 hours before implantation.  
Caprine Mesenchymal Stem Cell Collection and Culture  
The bone marrow was harvested from the goats’ sternum in the presence of 1 ml 
of 1,000 USP units/ml heparin per 10 ml of harvested bone marrow, using a 
previously described technique (36-38). The collected bone marrow was added to 




Adhered cells were washed with addition of HBSSc to remove extraneous blood 
agents and growth media, Dulbecco’s Modified Eagle Medium with glutamine, 4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES buffer), and sodium 
pyruvate added (DMEM/F-12 1:1 modified)d containing 10% fetal bovine serume 
(fetal bovine serum) and a 1% solution of 10,000 units/ml of penicillinf and 10,000 
µg/ml streptomycing (penicillin-streptomycin solution) was added. Cell cultures 
were expanded by regular media changes every 3 days until the cells reached 80% 
confluency, at which point cells were harvested using 0.25% trypsinh. Harvesting 
and seeding cycles were repeated to generate a stock of cells passage 2-4. For 
storage, aliquots of 10 million bone marrow-derived cMSCs were resuspended in 
1.5mL freezing medium, comprised of 50% fetal bovine serum, 5% dimethyl 
sulfoxide (Hybri-Max)i, and 45% of DMEM/F-12 1:1 modified media, and 
cryopreserved in liquid nitrogenj. For application, cells were thawed at 37°C, and 
re-suspended gently with DMEM/F-12 1:1 modified media and were carefully 
seeded to scaffolds 24 hours prior to implantation at a concentration of 5x106 
cMSC/cm of scaffold length. 
Surgical Procedure and Postoperative care 
The goats received antibiotics including ceftiofur sodiumk 2.2 mg/kg IV and anti-
inflammatories including flunixin megluminel 1 mg/kg for 3 days around the surgery 
time. Before the anesthesia, they were sedated with xylazine hydrochloridem (0.05 
mg/kg IV) and induced under general anesthesia using ketamine hydrochloriden 
(5mg/kg IV) and midazolamo (0.05 mg/kg IV). General anesthesia was maintained 
in dorsal recumbency using Isofluranep and oxygen. The right hind limb was 
clipped, aseptically prepped and draped accordingly to the surgery. A 20 cm skin 
incision was made over the dorsal and medial aspect of the right tibia to expose 
the bone and 5-7 cm full-thickness defect was created in the mid tibia with the 
oscillating bone sawq. The defect was stabilized with a 4.5 mm 8 holes – locking 
plater which was applied to the dorsomedial surface of the tibia. The plate was 
fixed to the bone with eight bi-cortical screwss, four in the distal and four in the 
proximal aspect of the tibia. The created void in the bone was thoroughly washed 
with a 10% gentamicint solution and the defect was filled either with the scaffold 
accordingly to previous treatment group assignment or left unfilled in the control 
group. The subcutaneous tissue was closed using absorbable taper sutureu in the 
simple continuous manner and the skin incision was closed using a simple 
continuous pattern with non-absorbable cutting suturev. A sterile bandage with the 
full limb splint support was applied to the right hind limb and the goat was 
recovered on the mat. During the postoperative care, the goats were housed 
individually for up to 30 days after the surgery and following that in the group pens 
containing 5-6 goats. The sutures were removed 30 days after the surgery and the 
full support bandages were removed 60 days after surgery. The fiberglass cast 
was applied to the limbs which required additional stabilization, including limbs with 
the locking plate constructs bending or limbs with the excessive periosteal reaction 




period, the bone healing assessment data was acquired, including thermography, 
radiography, dual X-ray absorptiometry (DXA), dual-phase Computed 
Tomography (CT) Angiography as well as histology. The peripheral blood was 
collected over several time points to evaluate the VEGF and BMP-2 concentration.  
High Definition Infrared Thermography (HD IR Thermography) 
Thermography was performed on the operated right hind limb to evaluate the blood 
flow in the local tissues associated with the inflammatory process using the high 
definition infrared thermometer cameraw. The camera was adjusted to the 
surrounding environment including the temperature and humidity each time before 
the data acquisition process was started. The acquisition process was 
standardized, and it was performed by two investigators (RG and RR). The scans 
were acquired 10 minutes after the bandage was removed. The scans were 
obtained 1 m away from the operated limb with the device directed perpendicularly 
to the limb and aimed at the area of interest in the center of the right tibia. Two 
projections obtained every time included the anterior-posterior projection as well 
as the latero-medial projection. The temperature was measured in both projections 
in degrees of Celsius and the average value was recorded.  
Radiography 
The new bone formation within the defects was assessed with the radiographic 
examination. The radiography was performed by two investigators (RG and RR) 
using the portable radiographic machinex, digital radiography platesy and a clinical 
radiographic digital systemz. The radiography involved two projections, the dorso-
plantar and latero-medial projection of the right tibia. The radiographs were 
obtained immediately after the procedure, 24 hours after the procedure, followed 
by monthly examinations until the end of the study. Obtained radiographs were 
exported in digital imaging and communications (DICOM) format to the picture 
archival and communication system (PACS)aa for the further analysis by the board-
certified radiologist (SH). The monthly radiographs were evaluated and the gap-
filling with new bone (range of scores from 0 to 4) (Table 4-1), opacity of newly 
formed bone (range of scores from 0 to 2) (Table 4-2) as well as opacity increase 
within the scaffold (0 – no and 1 – yes) were scored. The median scores were 
compared between the treatment groups. Next, the defects were monthly 
measured in three different locations. The first location consisted of the line drawn 
adjacent to the locking plate construct, the second location consisted of the line 
drawn in the center of the defect and the third location consisted of the line drawn 
in the far cortex. The defects showing evidence of collapse due to the locking plate 
bending were excluded from this analysis.  
Defect densitometry - Dual X-ray Absorptiometry (DXA) 
The bone density of the defects was measured with the dual x-ray absorptiometry 
(DXA)bb. The DXA system was calibrated based on two materials of defined 




area adjacent to the bone area. DXA scans were obtained 24 hours after the 
surgery followed by monthly examinations until the end of the study. The goats 
were sedated with Xylazine hydrochloridem (0.05mg/kg IV) and placed in sternal 
recumbency. The hind limbs were extended caudally and the scans of the entire 
length of the tibiae parallel to the long axis of the bone were performed. The 
scanner was set for the lumbar spine using a single beam and the bone mineral 
density (BMD) calculations were performed. The region of interest (ROI) was 
drawn between the most distal screw in the proximal bone segment and the most 
proximal screw in the distal bone segment. The ROI was subsequently divided into 
three segments (L1-L3), including the distal aspect of the proximal bone segment 
(L1), the defect (L2) and the proximal aspect of the distal bone segment (L3). All 
segments were analyzed in a DXA softwarebb and the report was generated. The 
bone area was defined and expressed in cm2 and BMD was calculated and 
expressed in g/cm2.  
Dual-Phase Computed Tomography (CT) Angiography 
The vascular integrity following large defect creation in the tibiae was assessed 
with the dual-phase computed tomography (CT) angiography. The CT was 
performed using a 40-slice helical CT scannercc. Obtained CT images were sent 
to the PACS systemaa for further evaluation by the board-certified radiologist (SH). 
The scans were performed before the goat was sacrificed under general 
anesthesia at two study termination time points (60 and 180 days). During the 
scans, the transverse images of the tibia from the distal aspect of the femur to the 
tarsus were obtained prior to contrast medium administration. The images were 
acquired as a multi-slice helical data set and were reconstructed into 0.67- and 5-
mm slices using soft tissue and bone algorithms. The dual-phase CT angiography 
consisted of two contrast injection phases, including test bolus of a contrast 
mediumdd (185 mg I/kg) administration and a full dose of contrast mediumdd (814 
mg I/kg) administration. The number of visible vessels surrounding the defect as 
well as their branches were recorded. The contrast enhancement was also 
measured as an indicator of vascularity of the tissues within the osteotomy gap. 
Attenuation values before contrasting medium administration and during peak 
arterial and venous enhancement were determined, and a contrast enhancement 
ratio between post- and pre-contrast measurements was calculated. The defect 
density was measured using Hounsfield Units (HU). 
Histology  
The goats received intravenous oxytetracyclineee (20 mg/kg IV) one time, 24 hours 
before euthanasia to label the metabolically active bone. After the euthanasia, the 
tibia segments were harvested and fixed in 95% Ethanol fixative until sectioned. 
The specimens with insufficient healing and tissue integrity to perform whole 
segment histology were divided into proximal, middle and distal segments. The 
proximal segment included 1-cm of the proximal bone and the transition zone 




of the scaffold, and the distal segment included 1 cm of the distal bone and the 
transition zone between bone and the scaffold. Those samples underwent routine 
protocol decalcification process which included preservation in 10% neutral 
buffered formalinff for 5 days after tissue biopsy followed by a short, up to 5 days 
decalcification with hydrochloric acidgg (39). The specimens were subsequently 
stained with hematoxylin-eosin and Masson’s trichrome according to the routine 
staining protocols (40-42). Tissues with sufficient bone healing and integrity were 
harvested in their entirety and ultimately embedded in methyl methacrylatehh for 
staining and analysis (40). The embedding process included tissue dehydration 
using an automated tissue processorii and placing the tissues in the infiltration 
solution (methyl methacrylate and dibutyl phthalate) for a period of 1.5 - 2 weeks. 
Infiltrated tissues underwent following staining, including von Kossa, Goldner’s 
Trichrome, Tartrate-resistant acid phosphatase (TRAP) and Verhoeff-Van Gieson 
(VVG) accordingly to the routine protocols previously described in the literature 
(43-45). For fluorescence microscopy, slides were coverslipped and left unstained 
due to the fluorochrome labeling to determine bone formation. Descriptive analysis 
and quantitative assessment of the stained specimens were performed. The 
quantitative assessment of new bone formation (mineralized tissue) in the proximal 
and distal segment as well as the osteoid (unmineralized tissue) formation in the 
middle sections was conducted using NIH Fijijj (46,47). The quantification was 
carried out through the generation of binary masks for images, permitting 
measurement of the mineralized and non-mineralized area relative to the total 
image area. Bone and osteoid areas expressed as a percentage of the total area 
of images were averaged, and statistical relations among groups obtained.   
VEGF and BMP-2 concentration measurement 
The peripheral blood was collected from the goats to evaluate the vascular 
endothelial growth factor (VEGF) and bone morphogenetic protein-2 (BMP2) 
concentration up to 30 days after surgery. The timeline was established according 
to the previous reports, which found the most dynamic changes in the 
concentration of those growth factors within the first month of the healing (48). The 
collected blood was centrifuged to obtain plasma which was stored in -80°C freezer 
until analysis. The analysis was performed using commercially available BMP2kk 
and VEGF ELISA kitsll which allowed for the measurements of the concentration 
of each growth factor. 
Statistical Analysis 
The statistical analysis was performed using IBM SPSS Statistics 25®mm. The 
treatment groups assigned to the 2-month time point and 6-month time point were 
analyzed separately. The descriptive statistics including mean values as well as 
standard deviations of each variable were performed. The continuous variables 
were tested for the normality of distribution using the Kolmogorov - Smirnov test 




The differences between the treatment groups at each data collection time points 
were analyzed using one-way analysis of variance (ANOVA) test with Tukey’s 
Post-hoc test with the treatment group as the factor. The changes within each 
treatment group over time were evaluated with the bivariate 2 – tailed Pearson’s 
correlation test and multivariate regression analysis with the treatment groups as 
the dependent variables and time as the covariate. The adjusted R squared as well 
as beta coefficients for each dependent variable were obtained and the 
significance of each beta coefficient was evaluated. The categorical data were 
compared between the treatment groups using the Kruskal – Wallis nonparametric 
test. The survival rate of the study population due to a complication occurrence 
was calculated using the Kaplan-Meier survival curve. The statistical significance 
of the tests was established at alpha equaled 0.05 and the power of the study was 
calculated to be β = 0.8.  
Results 
Study Population 
The study included 61 out of 67 mature female goats (> 2 years old). The goats 
were assigned to 2 study terminal time points, including 2-month (n = 30) and 6-
month (n=31). The average size of the defect created in the study was 6.63 ± 1.4 
cm in both time points. The average weight of the goats was 51.49 ± 8.0 kg and 
55.59 ± 7.9 kg in the 2- and 6-month treatment groups respectively. The calculated 
Kaplan-Meier survival curve revealed no statistical difference in the survival rate 
between all the treatment groups due to an event that was defined as a 
complication (p > 0.05) (Figure 4-1, all figures and tables are placed in the 
appendix). 
High Definition Infrared Thermography (HD IR Thermography) 
The statistical analysis confirmed the normality of data distribution and 
homogeneity of variance within all analyzed variables (p > 0.05). The analysis of 
data obtained from the goats assigned to the 2-month time point did not reveal 
statistically significant differences in the temperature yielded by the local tissues 
surrounding the surgery site between all treatment groups at any of the data 
collection time points. A statistically significant reduction of local tissue 
temperature over 2 months after surgery in all treatment groups was observed (p 
< 0.05). This was confirmed with the multivariate regression which was significant 
for all treatment groups and yielded following beta coefficients, -0.54, -0.47, -0.41, 
-0.58 and R2 values, 0.356, 0.219,0.132,0.090 for the control, scaffold, scaffold 
rhBMP-2 and scaffold cMSC treatment group respectively (p < 0.05).  
 
The analysis of data obtained from the goats assigned to the 6-month time point 
showed a similar trend, revealing no statistically significant differences in the 
temperature of the local tissues at any of the data collection time points (p > 0.05). 
A statistically significant reduction of local tissue temperature overtime after 




confirmed with the multivariate regression which was significant for all treatment 
groups and yielded following beta coefficients, -0.74, -0.77, -0.75, -0.80 and R2 
values, 0.663,0.710,0.728,0.706 for the control, scaffold, scaffold rhBMP-2, and 
scaffold cMSC treatment group respectively (p < 0.05) (Figure 4-2). 
Radiography 
The subjective radiographic assessment revealed that in the 2- and 6-month time 
points treatment groups, the scores of osteotomy gap filling, the scores of newly 
formed bone opacity as well as in the scaffold containing treatment groups - the 
scores of the opacity increase within the graft did not differ significantly between 
all treatment groups (p > 0.05) (Figures 4-3,4-9,4-10, and 4-11). The objective 
analysis involved the defect measurement results collected from 40 out of 61 goats 
(Figure 4-3). The results from 21 goats were excluded from this analysis due to the 
defect collapse during the postoperative period. The statistical analysis confirmed 
the normality of data distribution and homogeneity of variance within all analyzed 
variables (p > 0.05). The statistical analysis of the results obtained from the 2-
months treatment groups did not reveal significant differences between the 
treatment groups in general reduction of the defect at any of the measurement time 
points (p > 0.05) (Table 4-3). Similarly, the detailed analysis of 3 different defect 
measurement locations (lines 1,2 and 3) did not reveal significant differences 
between the treatment groups in the defect reduction at any of the measurement 
time points (p > 0.05) (Table 4-3). This was confirmed with the multivariate analysis 
which revealed no significant defect reduction over 2 months after the surgery (p 
> 0.05), except for the scaffold only treatment group for which the analysis showed 
a significant reduction in the size of the defect measured at the line no. 1 and 2 
(beta coefficient = - 0.161, R2 = 0.421 and – 0.113, R2 = 0.610 respectively) (p < 
0.05).  
 
The differences between the treatment groups in defect reduction were more 
noticeable in the goats assigned to the 6-month time point (Table 4-3). The 
calculated defect reduction slope was more dynamic within the first 3 months after 
surgery yielding -0.093 mm/day, -0.099 mm/day, -0.126 mm/day, -0.338 mm/day 
for the control, scaffold, scaffold rhBMP-2 and scaffold cMSC treatment group 
respectively. The slope plateaued after 3 months post-surgery, resulting in -0.028 
mm/day, -0.073 mm/day, -0.060 mm/day, -0.125 mm/day in the control, scaffold, 
scaffold rhBMP-2 and scaffold cMSC treatment group respectively (Figure 4-4). 
The statistical analysis of the general defect reduction revealed significant 
differences from the 3rd month after the surgery in the size of the defect between 
the scaffold cMSC and the remaining treatment groups (p < 0.05) (Table 4-3). The 
detailed analysis revealed that the defect reduction in scaffold cMSC differed 
significantly from the control treatment group 4-, 5- and 6-months after surgery in 
the line no. 3 as well as from the scaffold in the line no.1, 4 months after surgery 
and in the line no. 3, 4-, 5- and 6-months after surgery (p < 0.05) (Table 4-3). The 




differences in the defect size between the treatment groups at any of the data 
collection time points (p > 0.05) (Table 4-3). The results of the multivariate 
regression analysis of the measurements taken in line no.1 were statistically 
significant for all treatment groups and yielded following beta coefficients, -0.121, 
-0.098, -0.151, -0.311 and R2 values, 0.155, 0.087, 0.286, 0.376 for the control, 
scaffold, scaffold rhBMP-2, and scaffold cMSC treatment group respectively 
(Figure 4-4). The multivariate regression analysis of the measurements taken in 
line no.2 was statistically significant only for the scaffold containing treatment 
groups and yielded following beta coefficients, -0.093,-0.076, -0.301 and R2 
values, 0.097, 0.128, 0.335 for the scaffold, scaffold rhBMP-2 and scaffold cMSC 
treatment group respectively (Figure 4-4). The multivariate regression analysis of 
the measurements taken in line no.3 was statistically significant only for the 
scaffold cMSC treatment group and the beta coefficient equaled -0.273, as well as 
R2 value, equaled 0.309 (Figure 4-4).  
Densitometry - Dual X-ray Absorptiometry (DXA) 
The statistical analysis of the DXA results confirmed the normality of data 
distribution and homogeneity of variance within all analyzed variables (p > 0.05). 
The bone mineral density (BMD) recorded on the tibiae in the goats assigned to 
the 2-month time point varied between the treatment groups. At the 2-months data 
collection time point, the statistical analysis revealed significant differences in BMD 
between the treatment groups containing the scaffold and the controls (p < 0.05) 
(Table 4-4, Figure 4-5). The differences were however not statistically relevant 
between the scaffolds containing treatment groups (p > 0.05) (Table 4-4). The 
calculated BMD slopes varied between the treatment groups revealing 0.001 
g/cm2/day, 0.004 g/cm2/day, 0.005 g/cm2/day for the control, scaffold as well as 
scaffold rhBMP-2 and scaffolds cMSC treatment group respectively. The 
multivariate analysis confirmed the trend yielding following beta coefficients, 0.001, 
0.04, 0.001, 0.005 and R2 values, 0.077, 0.711, 0.665, 0.537 for the control, 
scaffold, scaffold rhBMP-2 and scaffold cMSC treatment group respectively (p < 
0.05). 
 
At 6-months data collection time point, the statistical analysis revealed significant 
differences in BMD between the treatment groups at all data collection time points 
(p < 0.05) (Table 4-4, Figure 4-5). The differences in BMD were found between the 
groups containing the scaffolds and the control (p < 0.05) (Table 4-4). Further 
analysis found statistically significant differences between the scaffold cMSC and 
the scaffold treatment group revealing lower BMD in the scaffold cMSC, 24 hours 
after the surgery and higher BMD in the scaffold cMSC, 4 and 5 months after the 
surgery (p < 0.05) (Table 4-4). The BMD was also significantly higher in the 
scaffold cMSC as compared with the scaffold rhBMP-2 at 4, 5 and 6 months after 
the surgery (p < 0.05) (Table 4-4). The differences between the scaffold and the 
scaffold rhBMP-2 were not statistically significant (p > 0.05) (Table 4-4). The 




revealing 0.0005 g/cm2/day, 0.0023 g/cm2/day, 0.0024 g/cm2/day, and 0.0048 
g/cm2/day increase within the control, scaffold, scaffold rhBMP-2, and scaffold 
cMSC respectively (Figure 4-6). After 2- and 3-months post-surgery, the BMD 
slopes gradually plateaued in all treatment groups, resulting in 0.0013 g/cm2/day, 
-0.0014 g/cm2/day, -0.0014 g/cm2/day, and 0.0021 g/cm2/day increase in the 
control, scaffold, scaffold rhBMP-2 and scaffold cMSC treatment group 
respectively (Figure 4-6). The multivariate regression confirmed the trend and it 
was significant in all treatment groups yielding following beta coefficients, 0.000, 
0.001, 0.001, 0.004 and R2 values, 0.075, 0.126, 0.126, 0.351 for the control, 
scaffold, scaffold rhBMP-2 and scaffold cMSC treatment group respectively (p < 
0.05) (Figure 4-6). 
Dual-Phase CT Angiography 
The statistical analysis of results obtained from the computed tomography (CT) 
with angiography confirmed the normality of data distribution and homogeneity of 
variance within all analyzed variables (p > 0.05). Further analysis of the results 
obtained from 2-month treatment groups revealed that defect density was 
significantly different between the scaffold containing treatment groups and the 
control (p < 0.05). The results were however not significantly different between the 
treatment groups containing scaffolds (p > 0.05) (Table 4-5). The density of newly 
formed bone and the number of newly formed vessel branches within the defect 
did not differ significantly between the treatment groups (p > 0.05) (Table 4-5). The 
number of vessels contacting the implant did not differ significantly between the 
treatment groups containing scaffolds (p > 0.05) (Table 4-5). The contrast 
enhancement ratio was significantly higher in the scaffold as compared with the 
scaffold cMSC treatment group (p < 0.05) (Table 4-5). Further analysis revealed 
that the cortical density of the proximal and distal bone fragment was significantly 
different between the operated limb and non-operated limb in control, scaffold 
rhBMP-2 and scaffold cMSC treatment group (p < 0.05). The difference was not 
statistically relevant in the scaffold treatment group (p > 0.05). The muscle mass 
of the gluteal muscle group was significantly different in the non-operated limb as 
compared with the operated limb in the scaffold and scaffold cMSC treatment 
group (p < 0.05). The difference was not statistically relevant in the control and 
scaffold rhBMP-2 treatment group (p > 0.05). 
 
The statistical analysis of results obtained from the computed tomography (CT) 
with angiography of the 6-month treatment groups revealed that defect density 
measured differed significantly between the scaffold containing treatment groups 
and the control (p < 0.05). The results were however not significantly different 
between the treatment groups containing scaffolds (p > 0.05) (Figure 4-12, Table 
4-5). The density of the newly formed bone and the number of newly formed vessel 
branches within the defect did not differ significantly between the treatment groups 
(p > 0.05) (Figure 4-4, Table 4-5). The number of vessels contacting the implant 




containing (p > 0.05) (Table 4-5). The contrast enhancement ratio did not differ 
significantly between the treatment groups (p > 0.05) (Table 4-5). Further analysis 
revealed that the cortical density of the proximal and distal bone fragment was 
significantly different between the operated limbs and non-operated in all treatment 
groups (p < 0.05). The muscle mass of the gluteal muscle group was significantly 
different in the non-operated limb as compared with the operated limb in the 
scaffold and scaffold cMSC treatment group (p < 0.05). The difference was not 
statistically relevant in the control and scaffold rhBMP-2 treatment group (p > 0.05).   
Histology 
The specimens harvested from the controls differed significantly in the 
macroscopic as well as the microscopic view from the scaffold containing 
treatment groups, similarly, among decalcified and undecalcified specimens. The 
controls involved only the proximal and distal bone segment as the newly formed 
bone did not bridge the defect in the controls (Figure 4-13). Furthermore, the 
medullar cavities of the proximal and distal sections were enclosed with the cortical 
bone consistent with early non-union changes. Bone segments treated with 
scaffolds had osseointegration of the scaffold ends within the medullary cavity. The 
ends of the bone segment remained open with new bone formation extending 
within the scaffold and growing on the surface of the implants. New bone on-growth 
along the surface of the scaffolds had extensive non-mineralized tissue containing 
high concentrations of collagen (osteoid) (Figures 4-13 and 4-14). The osteoid was 
well-formed within the pores and channels of the scaffolds, and it was equally 
distributed within all the sections of the implant. In the tissues harvested from 2-
month goats, the osteoid appeared more mineralized in the proximal and distal 
third of the scaffold and less within the center of the scaffold. This trend was less 
noticeable, as the osteoid mineralization was equally distributed across the 
specimen (Figure 4-14). The cortical bone was well integrated with the osteoid and 
newly synthesized cortical bone surrounding the implant. The periosteum 
presented a continuous extension from the proximal and distal bone segment to 
the newly formed bone and osteoid surrounding the implant. The unstained slides 
revealed a higher level of fluorescence which corresponded with higher bone 
metabolic rate in the specimens with lower mineralization, confirming that the bone 
formation in those specimens was more active as compared with the tissues 
already containing higher mineralization (Figure 4-15). The medullar cavity in all 
the specimens was filled with adipose tissue. The large polynuclear cells were not 
found in the transition zones between the bone segments and the scaffolds. 
Quantitative assessment of the scaffold treated specimens, harvested at 2 and 6 
months after surgery, did not reveal statistically significant differences between the 
treatment groups in the bone content in the proximal and distal sections as well as 
in the osteoid content in the middle sections (p > 0.05) (Table 4-6). There were no 
statistically relevant differences in the bone content and in the osteoid content 




VEGF and BMP-2 concentration measurement 
The results of the VEGF concentration analysis were not significantly different 
between treatment groups at any of the blood collection time points. Furthermore, 
the analysis did not reveal a significant linear change in the VEGF concentration 
within the treatment groups (Figure 4-7). The VEGF concentration increased from 
the baseline concentration over 10 days after surgery and then gradually 
decreased to the values before surgery, except in the control group (Figrue 4-7). 
The results of the rhBMP-2 concentration analysis revealed a significant linear 
increase of the rhBMP-2 concentration within the first month after the surgery 
among all treatment groups (Figure 4-8). The increase was noticed to be most 
dynamic in the treatment group containing the scaffold soaked in rhBMP-2 (2-fold 
of the baseline), followed by the treatment group with the scaffold coated with 
cMSC, scaffold only and the negative control. The rhBMP-2 concentration was 
significantly higher in the treatment group containing the scaffold soaked with 
rhBMP-2 10 and 30 days after the surgery as compared to the control and control 
and scaffold coated with cMSC respectively (Figure 4-8).      
Discussion 
The study showed promising results in bone regeneration using a novel technology 
3D nHA-PU-DBP bone scaffold, and therefore the first hypothesis (H1) of the study 
was accepted. The bone regeneration was however not associated with the 
macroscopic appearance of the neovascularization process. The second 
hypothesis (H2) that the bone scaffold will stimulate the neovascularization was 
therefore rejected. Similarly, the third (H3) and fourth hypothesis (H4) that there 
will be a significant difference in the bone regeneration and neovascularization 
between the treatment groups containing scaffolds were rejected. Another 
outcome of this study revealed that the concentration of the bone morphogenetic 
protein – 2 increased in the linear fashion among all treatment groups. 
Furthermore, the highest increase of this growth factor was noticed in the scaffold 
rhBMP-2 treatment group which was associated with the gradual release of 
rhBMP-2 from the scaffold.  
 
The bone scaffold significantly enhanced tissue regeneration in the scaffold 
containing treatment groups. This was constant among the outcomes of all 
assessment tools used in this study. The intervals of radiographs and DXA scans 
performed in the study were established accordingly to the previous reports using 
similar bone healing models, to most accurately detect the changes in the defect 
filling with the new bone (40,49-53). The bone healing was found to be significantly 
more dynamic within the scaffold cMSC treatment group. 2 goats assigned to this 
treatment group bridged the defect completely with a new bone. The defects 
healed in all goats in the same manner showing the most dynamic bone healing 
adjacent to the stainless-steel locking plate implant which has been already shown 
to be osteoconductive (35,54). Only the scaffold containing treatment groups 




the far cortices, surrounding the scaffold and justifying the osteoconductive 
properties of the utilized implant (35). The bone and osteoid formation occurred in 
the same manner among all the treatment groups growing within the implant 
equally from the proximal and distal segment of the bone towards the center. The 
radiography and DXA showed the most dynamic bone formation within the second 
and third month after surgery. Interestingly, the DXA revealed the most dynamic 
increase in BMD in the defect during the second month after surgery and the 
radiography showed the most dynamic defect reduction within the third month after 
surgery and thus one month after the BMD increase. In other words, the healing 
process started with the osteoid formation within the pores and interconnected 
channels of the implant and this was followed by the bone on growth on its surface 
what relates to the osteoinductive properties of the implant (35). The defect 
reduction plateaued gradually within the fourth, fifth and sixth months after surgery.  
 
The neovascularization is one of the most important processes in bone 
regeneration, as it provides oxygen and nutrients to the regenerating bone tissue 
(12-16). The angiogenesis in the regenerating bone occurs due to the enhanced 
mobilization of the bone marrow-derived endothelial progenitor cells (EPCs) and 
the new vasculature determines the architecture and quality of newly formed bone 
(15,16,55). The study did not find statistically significant differences in the number 
of newly formed vessel branches and branches contacting the scaffold between 
all the treatment groups. A trend was noticed however that the numbers were 
higher 2 months after the surgery as compared with the scans taken 6 months after 
the surgery. This can be explained by the fact that the neovascularization process 
has been found to be most dynamic during the early phases of bone regeneration 
(14). The lack of the statistically and clinically significant differences may be 
associated with the fact that the used CT machine was not sensitive enough to 
detect the microvasculature (50 µm – 500 µm) around the scaffold as well as within 
the scaffold. Because of the size of a goat limb, the utilization of a micro-CT to 
detect the microvessels was not possible. This study addressed this issue 
estimating the contrast enhancement ratio which was directly associated with the 
contrast concentration within the defect vasculature. In brief, the analysis of the 
contrast enhancement ratio, however, did not show a difference between the 
treatment groups. Summarizing, even though neither the scaffold nor the cMSC 
nor the BMP-2 significantly influenced the macro vasculature and the contrast 
concentration within the defect, they still could have had an influence on the 
microvasculature formation and architecture. Because of the above-mentioned 
limitations, the study findings regarding the neovascularization should be 
interpreted with caution.  
 
The bone marrow-derived allogeneic caprine mesenchymal stem cells (cMSCs) 
had a significant positive impact on bone healing. The defects in 2 goats (6.5 cm 
and 7.2 cm) which were assigned to the scaffold cMSC treatment group bridged 




been already proven to have bone regenerative capacity (31,32,46,52), however, 
because of the relatively small number of the goats with such outstanding results, 
the bone regeneration in those 2 cases was rather due to the cMSCs interaction 
with the host progenitor cells and not due to the pure benefit of the allogeneic 
cMSCs. The bone regeneration occurred in the scaffold rhBMP-2 treatment group 
was on the other hand not significantly different than that which occurred in the 
scaffold only treatment group, even though the rhBMP-2 has been also already 
proven to have a stimulative effect on osteogenic differentiation of both 
mesenchymal stem cells and osteoblasts (33,56,57). This may be related to the 
dose of E-BMP-2 used in this study which was 3 mg per scaffold (approximately in 
the concentration of 0.5 mg/cm3) or to the other factors influencing bone 
regeneration in such large segmental defects (51,58-60). Furthermore, the 
stimulative effect of BMP2 on angiogenesis has been already described in the 
literature as well (61-63).BMP2 is known to stimulate migration and tube formation 
of human endothelial cells (61-63). 
 
The peripheral blood vascular endothelial growth factor (VEGF) concentration 
analysis revealed no differences between treatment groups and no significant 
linear changes within 30 days after surgery. There was however an increase in 
VEGF concentration from the baseline concentration within the immediate 
postoperative period. The positive association between the VEGF concentration in 
the local tissues and bone regeneration has been already established in the 
literature (48,63-66). Increased secretion of VEGF has been found in osteoblasts 
during bone repair as well as in peripheral blood lymphocytes and platelets in 
patients with colorectal cancer (48,67). This study, however, did not find significant 
differences between the treatment groups in the peripheral blood VEGF 
concentration. This may be associated with the fact that the concentration 
oscillations correlated with a different pace of bone healing were very low in 
peripheral blood and hard to detect or that the size of defect influenced the 
concentration more than the pace of tissue regeneration. The analysis of 
peripheral blood BMP-2 concentration, on the other hand, revealed a significant 
linear increase in this growth factor in the peripheral blood within the 30 days of 
defect healing in all treatment groups. The increase was significantly higher in the 
scaffold BMP-2 treatment group as compared with the remaining groups, which 
was associated with the gradual release of BMP-2 from the implant.  
 
The bone scaffolds were made from biocompatible polyurethane (D3 PU) platform 
which was coated with nano-hydroxyapatite (nHA) (25,26). The scaffold 
architecture consisted of multiple PU-nHA platforms that were laid on each other 
and the decellularized bone particles (DBPs) which were placed in between the 
platforms. The PU used in this study is biologically stable for up to 30 days after 
implantation (25,26). The PU/nHA ratio is vital for optimal bone regeneration and 
it has been previously optimized, and it equaled 80 PU to 20 nHA (25,26). The 




range for bone regeneration. The polyurethanes have been previously employed 
in multiple biomedical devices (11,17-24) and recently they have gained an interest 
in the research due to the significant number of mechanical and biological 
advantages which allow them to be incorporated in the bone scaffolds. 
Furthermore, depending on the synthesis method, the porosity of synthetized PU 
can be controlled in a feasible way (11). They are an excellent candidate to serve 
as a platform for the bioactive nanomaterials including nano-Hydroxyapatite in the 
bone scaffolds (22-23). Nanostructured hydroxyapatite promotes fibroblastic cell 
(a model cell line) and osteoblastic cell (bone-forming cell) adhesion and 
proliferation, osseointegration, and the deposition of calcium-containing minerals 
on the surface of these materials (68-70). The rough surfaces of nHA are found to 
cause asymmetrical division of stem cells into osteoblasts which are also important 
for osteoinduction (70). The nanomaterials can alter the surface energy of 
materials to control initial protein adsorption and confirmation to inhibit 
inflammatory cell functions and promote tissue forming cell functions (71). The 
scaffolds coated with nano-HA have been known to improve the mechanical 
properties, including increased compressive strength (maximum 0.45 versus to 
0.16 MPa for no coating) and elastic modulus (maximum 1.43 versus 0.79 for no 
coating) (11,72,73). The final advantage of nano Ha is a porous structure with a 
high-binding affinity makes it an excellent drug delivery device and the low 
solubility of nano-HA under physiologic condition contributes to its longer 
degradation rate and allows the drug delivery in a more controlled manner (70,74-
78). Therefore, the nHAP particles have been shown to be excellent carriers of 
antibiotics (75), anticancer drugs (76), growth factor (77) and enzymes (77,78) for 
its notorious adsorption ability. 
We encountered several complications while conducting this study, including 
orthopedic locking plate bending, excessive periosteal reaction, plate pullout from 
the proximal bone segment, fractures of the proximal and distal bone segments as 
well as surgery side infections. The scaffold migration after implantation was 
observed within 24 hours post-implantation and in all cases, the implant migrated 
caudally at its insertion into the distal segment of the tibia. The study utilized a not 
commonly used in the research large segmental (up to 7 cm) and full-thickness 
tibial defect and some amount of above-mentioned complications were to be 
expected. The most common complications included the orthopedic plate bending 
and excessive periosteal and endosteal reaction. Neither of them was associated 
with the weight of the goat or with the size of the defect (Table 4-7). In the authors’ 
subjective opinion, the goats which encountered plate bending showed a higher 
level of activity in the postoperative period. This was however not assessed in an 
objective manner. The excessive periosteal and endosteal reactions occurred in 
both cortices around the screw implants and could have resulted from an instability 
in the plate-screw constructs. The further complications including fractures and 
infections occurred in the goats with a higher size of the defect (above 7 cm) and 
it can be therefore concluded that they were related to the size of the defect and 




goats because of a higher amount of created dead space after the segment 
removal. All the complications occurred within the first and second months after 
the surgery. The overall survival rate in this study was calculated at 91% (61/67 
goats).  
Conclusions  
Bone scaffolds not only provided the surface for the bone on growth 
(osteoconduction) but also stimulated the bone ingrowth within the implant 
(osteoinduction) as well as around the implant (osseointegration) as compared 
with the negative controls. Furthermore, the tested bone scaffolds were excellent 
delivery devices for the bioactive agents such as the human recombinant bone 
morphogenetic protein-2 and caprine mesenchymal stem cells which significantly 
stimulated and enhanced bone regeneration. Neither the scaffolds, scaffolds with 
rhBMP-2, nor scaffolds with cMSC improved the macro angiogenesis in the 
regenerating bone. However, their influence on the microvasculature formation 
remains unknown. Furthermore, the bone scaffolds used in this study did not cause 
excessive inflammatory processes within the healing defects as compared to the 
control defects. The animal model with such a magnitude of the tibial segmental 
defect (> 6 cm) has been successful as the bone regeneration model with a high 

























Table 4-1. Radiographical ostectomy gap scoring. 













Ostectomy Gap Filling 
Score Ostectomy gap filling 
0 No interval change compared to immediate post-operative radiographs 
1 New bone filling <25% of ostectomy gap 
2 New bone filling 26-50% of ostectomy gap 
3 New bone filling 51-99% of ostectomy gap 
4 
Ostectomy gap completely filled and/or bridging callus present on at 
least 3 cortices 
Opacity of new bone 
Score Opacity of new bone  
0 No interval change compared to immediate post-operative radiographs 
1 New bone less opaque than normal cortex 

















Time point After 2 Months Post OP After 6 Months Post OP 






















Control 2.8 4.9 2.1 3.3 19.5 8.1 2.0 9.9 
±5.1 ±8.1 ±2.8 ±5.5 ±18.
6 
±7.5 ±4.1 ±13.4 
Scaffold 5.8 5.5 3.3 4.9 20.0 13.2 9.4 14.2 
±6.8 ±2.1 ±3.1 ±4.3 ±11.
9 
±3.8 ±5.5 ±8.7 
Scaffold + 
rhBMP-2 
2.7 2.6 -2.1 1.1 27.0 14.5 6.6 16.1 
±4.8 ±2.9 ±2.4 ±3.9 ±9.1 ±2.5 ±2.9 ±10.2 
Scaffold + 
cMSC 
4.1 3.7 4.4 4.1 43.5 41.9 36.8 40.8 










Table 4-4. BMD results comparison. 
 
Table 4-5. CT Evaluation  
 
BMD (g/cm2) Comparison Table  
Tx 
Group 
2 Months 6 Months 
D0 M1 M2 D0 M1 M2 M3 M4 M5 M6 
Control 
0.00 0.01 0.07 0.00 0.00 0.01 0.05 0.07 0.05 0.07 
±0.0 ±0.0 ±0.1 ±0.0 ±0.0 ±0.0 ±0.1 ±0.1 ±0.1 ±0.1 
Scaffold 
0.29 0.42 0.51 0.38 0.47 0.56 0.58 0.53 0.48 0.46 
±0.0 ±0.1 ±0.1 ±0.1 ±0.0 ±0.0 ±0.0 ±0.1 ±0.1 ±0.1 
Scaffold 
+ BMP2 
0.27 0.41 0.51 0.31 0.45 0.52 0.53 0.49 0.45 0.40 
±0.0 ±0.1 ±0.1 ±0.0 ±0.0 ±0.0 ±0.1 ±0.1 ±0.1 ±0.1 
Scaffold 
+ cMSC 
0.27 0.42 0.56 0.27 0.43 0.64 0.68 0.75 0.80 0.80 
±0.0 ±0.1 ±0.2 ±0.0 ±0.1 ±0.2 ±0.3 ±0.3 ±0.4 ±0.5 









Control 40.71 ±4.07 0.00 28.86 ±21.63  
0.00 
 
Scaffold 857.00 ±75.35 777.67 ±128.47 
Scaffold + 
rhBMB2 
803.88 ±83.36 625.86 ±121.84 
Scaffold + 
cMSC 




Control 930.00 ±274.66 0.57 1050.80 ±347.40  
0.53 
 Scaffold 665.33 ±229.80 1200.60 ±201.09 
Scaffold + 
rhBMB2 
809.00 ±243.30 1170.17 ±190.56 
Scaffold + 
cMSC 



























Scaffold 40.71 ±12.51 23.56 ±12.00 
Scaffold + 
rhBMB2 
32.50 ±21.17 21.29 ±7.78 
Scaffold + 
cMSC 




the graft  






Scaffold 9.43 ±4.16 4.56 ±2.46 
Scaffold + 
rhBMB2 
8.13 ±4.45 5.43 ±2.70 
Scaffold + 
cMSC 










Scaffold 253.00 ±48.85 200.33 ±62.38 
Scaffold + 
rhBMB2 
236.25 ±43.62 215.86 ±56.76 
Scaffold + 
cMSC 










Scaffold 310.57 ±62.87 228.44 ±47.29 
Scaffold + 
rhBMB2 
269.13 ±51.06 248.14 ±52.27 
Scaffold + 
cMSC 










Scaffold 1.23 ±0.08 1.18 ±0.16 
Scaffold + 
rhBMB2 
1.14 ±0.07 1.17 ±0.09 
Scaffold + 
cMSC 








Table 4-6. Bone and osteoid formation. 
 






Complication description: 0 – study population, 1 – orthopedic plate bending, 2 – 
excessive periosteal reaction, 3 – scaffold migration, 4 – deep infection, 5 – split 
fracture of the bone fragment.  
 (%) 2 - Month Treatment Groups 






50.7 46.9 47.9 50.2 
±18.9 ±11.7 ±15.4 ±9.2 
Middle 
0.0 43.0 38.5 45.3 
±0.0 ±10.7 ±17.9 ±3.8 
Dist 
63.2 51.0 58.2 52.4 
±10.7 ±12.7 ±12.0 ±5.5 
 (%) 6 - Month Treatment Groups 
Prox 
57.1 43.8 44.8 50.3 
±15.6 ±13.8 ±7.9 ±13.5 
Middle 
0.0 43.7 44.8 50.2 
±0.0 ±9.7 ±16.6 ±12.5 
Dist 
58.4 40.1 50.1 48.5 
±12.1 ±10.1 ±18.4 ±9.9 
Number of complications 
Complication 0 1 2 3 4 5 
No of goats 61.0 17.0 11.0 4.0 3.0 4.0 
% of goats 100.0 28.0 18.0 6.6 4.5 6.6 
Average 
Defect Size 
6.6 6.7 6.2 5.3 7.4 7.1 
±1.4 ±1.4 ±1.5 ±1.6 ±0.4 ±1.7 
Average 
Weight 
55.6 55.4 54.1 57.0 40.7 50.3 


















































Figure 4-6. BMD curve.  

































Figure 4-9. Defect Comparison.  
The comparison of defects assigned to different treatment groups, 2 months after 
surgery (A) and 6 months after surgery (B). The treatment groups in both time 


















Figure 4-10. Representative defect cMSC healing.  
The sequential monthly radiographic evaluation of the representative defect of ana 
goat assigned to the 6 months scaffold cMSC group. The images are organized 
from left side in following order - day 1 after the surgery, 1 month, 2 months, 3 




Figure 4-11. Defect measurements.  
Defect measurements in goat assigned to the 6 months scaffold only treatment 
group. The first image on left side shows defect 1 month after surgery, image in 
the middle shows the defect 3 months after surgery and the last image from left 
side shows the defect 6 months after the surgery. The defects were measured in 




Figure 4-12. 3D CT reconstruction.  
Representative image of Computed Tomography – Angiography. Osteotomy limbs 
were directed towards outside of this image. Note, increased density of vasculature 
after the surgery as well as new vessel branches entering the scaffold from 
proximal side. This goat was assigned to the 6-month study time point, scaffold 














Figure 4-13. 2-month goats histology. 
Tissues harvested from goats assigned to the 2-month time point. Presented 
specimens have been stained according to the Masson’s trichrome protocol. The 
red color is associated with mineralized tissue whereas blue color is associated 
with non-mineralized tissue. Mineralized tissue has been defined as bone and non-
mineralized tissue as osteoid. Tissues have been divided into proximal, middle and 
distal sections. The figure contains representative images of, beginning from left, 
control, scaffold, scaffold with rhBMP2 and scaffolds with cMSC respectively. 
Difference in bone content was not found to be statistically significant between 
treatment groups, as well as difference in osteoid within scaffold was not found to 





Figure 4-14. 6-month goats histology. 
Tissues harvested from goats assigned to the 6-month time point. Specimens were 
harvested in their entirety and processed undecalcified. Presented specimens 
were stained accordingly to von Kossa protocol. The mineralized tissue with high 
calcium concentration stained black, whereas the non-mineralized tissue stained 
blue. The figure shows representative specimens of three treatment groups, 
beginning from left, scaffold, scaffold with rhBMP2, and scaffold with cMSC 













Figure 4-15. Fluorescence of 6-month specimens.  
Tissues harvested from goats assigned to the 6-month time point. The images in 
the top row were left unstained to evaluate fluorescence associated with 
metabolically active bone and images in bottom row were stained accordingly to 
Goldner’s trichrome protocol. It was noticed that the specimens with tissue 
containing a higher amount of non-mineralized tissue (red stain in Goldner’s) 
presented higher fluorescence as compared with the specimens containing a 
higher amount of mineralized tissue (green stain in Goldner’s). The figure presents 
unstained slides of tissues harvested from three different treatment groups, 
beginning from left, scaffold, scaffold with rhBMP2, and scaffold with cMSC with 










ANOVA – Analysis of Variance  
BMD – Bone Mineral Density 
BMP2 – Bone Morphogenetic Protein-2 
rhBMP2 – human recombinant Bone Morphogenetic Protein-2 
cMSC – caprine Mesenchymal Stem Cells 
CT – Computed Tomography 
DBP – Decellularized Bone Particles 
DMEM - Dulbecco’s Modified Eagle Medium 
DICOM – Digital Imaging and Communications  
DXA – Dual X-ray Absorptiometry 
HBSS – Hanks Balanced Salt Solution  
HU – Hounsfield Units  
nHA – nanophase Hydroxyapatite 
PACS – Picture Archival and Communication System  
PU – Polyurethane  
ROI – Region of Interest 
TRAP – Tartrate-resistant acid phosphatase 
VEGF – Vascular Endothelial Growth Factor 


























a. Recombinant human bone morphogenetic protein – 2, SBH Sciences Inc, 
Natick, MA  
b. T175 tissue culture flask, Fisher Scientific, Hampton, NH 
c. Hank’s Balanced Salt Solution, 500 ml, HyClone Laboratories, Logan, UT 
d. Dulbecco’s Modified Eagle Medium with glutamine, HEPES buffer, 
pyruvate, HyClone Laboratories, Logan, UT 
e. Fetal bovine serum, Life Technologies, Eugene, OR 
f. Penicillin, HyClone Laboratories, Logan, UT 
g. Streptomycin, HyClone Laboratories, Logan, UT 
h. Trypsin, Trypsin 0.25% 1x, HyClone Laboratories, Logan, UT 
i. Dimethyl sulfoxide, Hybri-Max, Milipore-Sigma, St. Louis, MO 
j. Liquid Nitrogen, HyClone Laboratories, Logan, UT 
k. Ceftiofur sodium, 1g powder, Naxcel, Zoetis, Parsippany-Troy Hills, NJ  
l. Flunixin meglumine, 50mg/ml, Prevail, VetOne®, Boise, ID   
m. Xylazine hydrochloride, Xylamed, 20 mg/ml, VetOne®, Boise, ID   
n. Ketamine hydrochloride, Zetamine, 100 mg/ml, VetOne®, Boise, ID  
o. Midazolam, 5 mg/ml, Akorn, Ann Arbor, MI   
p. Isoflurane, 250 ml, VetOne®, Boise, ID      
q. Oscillating bone saw,  
r. 8-hole 4.5 mm locking plate, Veterinary Orthopedic Implants, St. 
Augustine, FL  
s. 4.0 locking head screws, Veterinary Orthopedic Implants, St. Augustine, 
FL  
t. Gentamicin sulfate,100mg/ml, VetOne®, Boise, ID   
u. PDS II - Polydioxanone #2-0 (3.0 metric) suture with CT-1 36 mm 1/2c 
taper needle, Ethicon, Guaynabo, Puerto Rico 
v. SurgiproTM – Polypropylene monofilament #0 (3.5 metric) suture with C-
17 39 mm 3/8 cutting needle, Covidien, Mansfield, MA 
w. Fluke VT04A Visual IR Thermometer, Fluke Corporation, Everett, WA  
x. Portable radiography machine, Philips Easy Diagnost RF System, Philips 
International B.V., Amsterdam, Netherlands 
y. Digital radiography plates (CXDI-50G), Canon USA, Inc., Melville, NY 
z. NEXT Equine DR™ EDR6, Sound - Eklin®, Sound Technologies, 
Carlsbad, CA 
aa. PACS system, Spectra PACS IDS7, Spectra AB, Linkoeping, Sweden 
bb. Dual X-ray Absorptiometry system, QDR 4500 Hologic Inc. 
cc. CT scanner, Philips Brilliance-40, Philips International B.V., Amsterdam, 
Netherlands 
dd. OptirayTM 350, Mallinckrodt Inc, Hazelwood, MO 
ee. Oxytetracycline, 200 mg/ml, Liquamycin®, Zoetis, Parsippany-Troy Hills, 
NJ  
ff. Decalcifying solution protocol A, Fisher Scientific, Hampton, NH 




hh. PMMA, Sigma-Aldrich, Histological Grade, St. Louis, MO 
ii. Automated tissue processor, ASP300S, Leica, Germany 
jj. Fiji, ImageJ, National Institute of Mental Health, Bethesda, Maryland 
kk. BMP2 ELISA kit, ABclonal, Woburn, MA 
ll. VEGF ELISA kit, ABclonal, Woburn, MA 
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CHAPTER FIVE  
EFFECTS OF NOVEL 3D BONE SCAFFOLD ON THE HEALING 






















Bone regeneration remains a challenge in horses. Scenarios in which horses may 
benefit from enhanced bone healing include comminuted fractures, subchondral 
bone cysts, osteoarthritis and bone infections. This study aimed to assess bone 
regenerative capacity of a nano Hydroxyapatite polyurethane bone scaffold. The 
scaffolds were evaluated in five horses. Study design included 10 splint-bone 
defects assigned to scaffold (n=5) and control treatment group (n=5). Two cm full-
thickness defects were created in both fourth metacarpal bones in each horse. 
Bone healing assessment conducted over the ensuing 60 days included high 
definition infrared thermography camera, ultrasonography, radiography, and 
computed tomography. Histological evaluation of the tissue filling each defect was 
conducted at the termination of the study. 
Results 
The analysis of radiography revealed a significantly higher percentage of new bone 
formation (67.42% of the defect size) within defects containing bone scaffold as 
compared to defects left unfilled (35.88% of the defect size). Further analysis of 
computed tomography images revealed that defects containing bone scaffold had 
a significantly higher density as compared to the control (807.80 HU and 464.80 
HU in defects with bone scaffold and control respectively). Neither ultrasound nor 
thermography revealed signs of adverse effects associated with bone scaffold 
implantation. Histological evaluation confirmed significant bone formation within 
the pores and channels as well as on the surface of the bone scaffold.  
Conclusions 
The novel bone scaffold technology showed to be osseointegrative in current 
research model. The implant can be utilized to enhance the bone regeneration in 
horses affected by subchondral bone cysts, comminuted fractures with bone loss 
or in horses requiring arthrodesis. The unique design and composition of the 
implant allows for potential use as a drug delivery device.  
Introduction 
Bone injuries resulting in tissue loss and mechanical impairment are common in 
equine athletes. Examples include fractures (1-4), subchondral bone cysts (5-10), 
and bone infection (11-14). Fractures have been estimated to cause up to 63% of 
fatal injuries in the racing industry (1-3) and approximately 34% of them are 
comminuted with a variable degree of bone loss (2,4). Bone regeneration remains 
challenging in equids due to delayed or poor healing, repair failures resulting from 
high-stress loads, and infection (11-14). Prolonged convalescence is further 
associated with life-threatening complications, such as contralateral limb laminitis 




To date, autologous cancellous bone graft (autograft) is the gold standard to fill in 
the void in bone because of the low rejection risk as well as high osteoprogenitor 
cell concentration (17,18). Limitations of autografts include the necessity of a 
second surgery site, increased risk of infection, and a limited amount of donor 
tissue available (19,20). Because of the limitations, an ideal substitute for an 
autograft is desirable. It should be osteoinductive, osteoconductive and 
osseointegrative (21). Several allogenic materials have been tested in horses; they 
are however lacking three-dimensional structure and adequate mechanical 
properties (22-25)  
The objective of this study was to evaluate regenerative capacity of a three-
dimensional hydrophilic polyurethane platform coated with hydroxyapatite 
nanoparticles (nHA) and decellularized bone particles (DBP) (26). Hydrophilic 
polyurethane (PU) is a biocompatible synthetic polymer with stable biological and 
mechanical properties (26). Nanostructured hydroxyapatite has been shown to 
promote fibroblastic and osteoblastic cell adhesion and proliferation 
(osteoinduction and osteoconduction), provide calcium-containing minerals, and 
change the energy of coated materials to control initial protein adsorption as well 
as change the conformation to inhibit inflammatory cell functions (27-31).  
The bone scaffold was evaluated in defects that were created in the fourth 
metacarpal bones of horses. This has been established as an acceptable model 
of equine bone healing (22,32-38). The hypothesis was that the bone scaffold will 
be osteoinudctive, osteoconductive and osseointegrated, and therefore will 
enhance bone regeneration within the implanted defects as compared to the 
contralateral non-implanted control. 
Materials and Methods 
Study Population and Study Design   
The study was conducted on mares acquired for this study from local vendors and 
owned by the University of Tennessee, College of Veterinary Medicine (UTCVM). 
The study was approved by the University of Tennessee Institutional Animal Care 
and Use Committee and was conducted according to the IACUC protocol #2609-
0518. Horses were screened for general health as well as orthopedic conditions. 
Horses which showed signs of systemic diseases (e.g. bronchitis, pneumonia, 
chronic weight loss, colitis, etc.), were lame or had palpable abnormalities the 
fourth metacarpal (MC IV) bones, were not included in the study. The fourth 
metacarpal bones of each horse were randomly assigned to one of two treatment 
groups, S – bone scaffolda (n=5) and C – control (n=5).  
Study Timeline 
Horses were quarantined 14 days prior to the study. Each horse was transported 
from the farm to the veterinary teaching hospital 48 hours before the scheduled 




postoperative care which involved physical examinations and perioperative 
medications. The horses' activity was restricted to stall rest for 14 days after 
surgery so as not to compromise surgical site healing and to prevent bone scaffolda 
displacement. After 14 days, sutures were removed, and the horses were allowed 
access to small runs in front of the stalls for an additional 14 days. Forelimbs were 
kept bandaged for 21 days following the surgery after which the wounds were 
covered with standing wrap bandages for another 9 days. Thirty days after surgery, 
the horses were turned out on pasture for an additional 30 days before tissue 
biopsy was performed. 
Bone scaffold implantation surgery 
Perioperative treatment included gentamicin sulfateb (6.6 mg/kg IV, q24h), 
penicillin procaine Gc (22,000 IU/kg IM, q12h), and a non-steroidal anti-
inflammatory – firocoxibd (0.3 mg/kg IV, q24h). The horses were sedated with 
acetylpromazine maleate (0.04 mg/kg IM) followed approximately 30 min later by 
xylazine hydrochloridee (1.0 mg/kg IV). Anesthesia was induced with ketamine 
hydrochloridef (2.2 mg/kg, IV) and midazolamg (0.05 mg/kg, IV). Anesthesia was 
maintained with isofluraneh in oxygen (3 L/min) and xylazine hydrochloridee (1 
mg/kg/h). Horses were placed in dorsal recumbency and both forelimbs were 
clipped from the hoof to above the carpus. The surgical site was aseptically 
scrubbed and draped for aseptic surgery. A 5 cm long incision was created over 
the middle third of the left MCIV. Subcutaneous tissue was bluntly separated to 
expose the bone. A 2 cm long fragment of the MCIV was removed using an 
oscillating bone saw. Care was taken not to injure the underlying suspensory 
ligament during the procedure. The created defect was either filled with bone 
scaffolda or left unfilled according to the treatment group assignment. Prior to 
implantation, the bone scaffoldsa were soaked in 1 ml of sterile saline to allow the 
implant to absorb the fluid and increase its volume (Figure 5-1, all figures and 
tables are placed in the appendix). Subcutaneous tissue was closed in a simple 
continuous pattern using absorbable suturei and skin was closed in the simple 
continuous pattern using non-absorbable suturej. Surgery on the right MCIV was 
performed in the same manner as on the left MCIV. Sterile wraps were temporarily 
placed on both forelimbs and CT was performed to establish the baseline of defect 
density. Following CT, sterile distal limb bandages were placed, and the horse was 
allowed to recover from general anesthesia. Antibiotics as previously described 
were administered for an additional 48 hours. NSAID's as previously described 
were administered for an additional 72 hours.  
Data acquisition throughout the study 
The amount of postoperative inflammation surrounding the implant, including soft 
tissue swelling and local fluid accumulation, was assessed with ultrasonography 
and thermography. Thermographyk was recorded in degrees Celsius (°C) by the 
same investigator (RG) in two projections, anteroposterior and lateral-medial 




camera was adjusted to the environmental temperature and humidity and the 
recording was performed 5 min after bandage removal to allow the limb to cool 
down. Thermography was performed on the days 1, 3, 5,7,10,14,21,30 and 59 
following surgery. One 45° dorsolateral-palmaromedial oblique (DLPMO) 
projection of each MC IV bone was recorded  using a portable radiograph machine l 
on standing horses day 1 (Figure 5-2) after  surgery followed by day 14, 30 and 
59. Ultrasonography was performed by one investigator (RG) using a portable 
ultrasound machinem on standing horses day 1 (Figure 5-3) after  surgery followed 
by day 14, 30 and 59. The CT was carried out using a 40-slice helical CT scannern 
immediately after implantation surgery and again 60 days post-implantation 
immediately before tissue biopsy (Figure 5-4). Transverse images were 
reconstructed in 0.67- and 5-mm slice thickness, and sagittal and dorsal 
multiplanar reconstructed (MPR) images were generated. Images were sent to 
picture archive and communication systemo. The biopsied tissue was submitted 
for histological evaluation. 
Data Analysis  
The data collected from bone healing assessment was organized in Excelp 
spreadsheets. Radiographs and CT images were evaluated by a board-certified 
radiologist (SH) and scored for osteotomy gap filling as well as opacity of a new 
bone (Tables 5-1 and 5-2). The two individual scores were summarized for an 
overall radiographic healing score of each defect. Quantitative assessment of 
defect filling with new bone was performed on the radiographs using the NIH Fiji 
softwareq by the principal investigator (RG). Quantification was conducted through 
the generation of binary masks (black background and white color for bone) for 
images and drawing the region of interest (ROI) covering entire defect. The defect 
filling was calculated as the amount of white color (bone) within the ROI and 
expressed as percent of the defect area. The CT images were scored for new bone 
formation (Table 5-3) and the visibility of graft material on the CT images were 
recorded as being present or absent. A transverse slab was reconstructed 
spanning the length of the defect for both the study and control leg, and density of 
the defect was measured quantitatively with the results being expressed in 
Hounsfield Units (HU). Ultrasonography images were descriptively evaluated for 
any signs of inflammation surrounding the filled or unfilled defects. 
Tissue Biopsy  
At the termination of the study (60 days post implantation), the horses underwent 
CT and tissue biopsy. The perioperative treatment was as previously described. 
General anesthesia was induced as previously described. Horses had CT of both 
forelimbs performed and then both forelimbs were prepared for aseptic surgery in 
the same manner as previously described. A 5 cm long incision was created above 
the location of the previously created defect in both forelimbs and subcutaneous 
tissue was bluntly separated to present the defect. A 5 mm thick biopsy was 




Care was taken not to injure the underlying suspensory ligament during the 
procedure. Subcutaneous tissue and skin were closed as previously described. 
Sterile distal limb bandages were applied to both forelimbs and the horse was 
allowed to recover. Tissue was subsequently submitted for the histological 
evaluation. Postoperative care was as previously described. 
Histology 
Histology was performed on decalcified specimens. Each tissue specimen was 
preserved in 10% neutral buffered formalin (NBF)r for 48 h after tissue biopsy and 
was then decalcified with 15% formic acid for up to 14 days after tissue harvest. 
Specimens were cut with a scalpel and were stained with Hematoxylin and Eosin 
(H&E) for histologic evaluation. Histologic sections were analyzed using a light 
microscope at 10, 20 and 100 X magnification. The area available for tissue in-
growth was analyzed and described.  
Statistical Analysis   
The analysis was performed using SPSS statistical softwares and PS power and 
sample calculation softwaret. Descriptive statistics were determined for the 
continuous variables including thermography, percentage of defect filling as well 
as defect density after bone scaffolda implantation and before biopsy. The 
normality of data distribution of each variable was performed using a Kolmogorov-
Smirnov test of normality. The variables with continuous data were compared 
between the treatment groups using a paired-samples student T-test. The 
variables with categorical data were compared between the treatment groups 
using the Wilcoxon Signed Ranks test. The statistical significance was assumed 
at α = 0.05. The calculated power of the study design and carried out evaluations 
to detect the true difference in the filling of the defect with the new bone was β = 
0.9. 
Results 
The study included five adult mares (4 -10 years of age) with a mean weight of 
437.7 kg (± 29 kg). The breeds of the horses included Thoroughbred (n=1), Quarter 
Horse (n=1), Rocky Mountain Horse (n=1), Standardbred (n=1) and unknown 
(n=1). The bone scaffolds, after being soaked in sterile saline, increased by 100% 
of its original volume, however, the soaking did not compromise their integrity. The 
bone scaffolda remained mechanically tunable and handling, as well as the 
implantation process, were accomplished with no damage to bone scaffolda 
(Figure 5-1). None of the adverse effects were detected after implantation, 
including excessive swelling, seroma formation, or surgical site infection. The 
analysis of the high definition infra-red (HD-IR) thermography did not reveal 
significant differences between the treatment groups in the temperature of the 
superficial tissues over the surgery site immediately after the surgery (p>0.05). 
The temperature gradually decreased over 60 days after surgery equally in both 




Radiographically, the defects with bone scaffolds contained a significantly higher 
percentage of bone 60 days after the implantation, as compared to controls 
[67.42% (±26.7%) in the bone scaffolda group and 35.88% (±32.69%) in the control 
group (p=0.013)] (Figure 5-2, Table 5-4). In one of the five horses, the bone 
scaffolda was slightly displaced in the proximal aspect, but this did not interfere 
with bone formation within the defect. The qualitative assessment of the 
radiographs failed to show a statistically significant difference between the 
treatment groups (p>0.05). However, the bone scaffolda treatment group showed 
a trend of a higher median gap-filling and new bone opacity score as compared to 
the control (Figure 5-8). The qualitative assessment of the CT images, including 
the amount of newly formed bone within the defect was significantly higher in the 
bone scaffolda group as compared with the control group (p=0.038).  
Quantitatively, the density of new bone filling the defects in the bone scaffolda 
group was significantly higher than that in the control, revealing 807.80 HU 
(±129.63 HU) and 464.80 HU (±81.27 HU) respectively (p=0.002) (Figure 5-4 and 
Figure 5-9). Fourteen days following the implantation, ultrasonography revealed 
mild to moderate homogeneous fluid accumulation around the bone scaffolda and 
soft tissue swelling (Figure 5-3). Neither the fluid accumulation nor the soft tissue 
swelling was different from that of the defect in the control group. Serial 
ultrasonographic evaluation confirmed gradual bone formation around the bone 
scaffold, which was evident as a smooth hyperechogenic line at the surface of the 
implant (Figure 5-3). Histology confirmed significant bone formation within the 
pores and channels of the implant and around the implant (Figure 5-5). Analysis 
of the histological slides revealed several cartilage clusters within the bone tissue. 
In contrast, the center of the control was filled with connective tissue with no signs 
of bone formation (Figure 5-6).  
Discussion 
The study presented promising results in the enhancement of bone regeneration 
using the bone scaffolda in equids. The results were statistically and clinically 
significant as well as the calculated power of the study (β=0.9) revealed that 90% 
of the outcome was not related to a chance. The surgeries were rapid and scaffold 
manipulation as well as implantation was feasible in all cases. The bone scaffolds 
absorbed entire 1 ml of sterile saline after being soaked before the surgery. The 
fluid absorption increased the size of the implant by approximately 100%, however 
this did not compromise its integrity. The proximal aspect of one out of five implants 
was mildly displaced within the defect in the abaxial direction, however it did not 
interfere the bone healing. None of the horses developed adverse effects 
associated with the scaffold implantation.  
The defects containing the scaffolds in all 5 horses were filled in with a higher 
amount of the new bone as compared to the negative control on the contralateral 
limb. The amount of new formed bone varied similarly within the treatment groups 




the bone scaffold is osseointegrative in equids was accepted. These terms mean 
that the scaffold did stimulate the primitive, undifferentiated and pluripotent cells to 
produce the bone lineage (osteoinduction) as well as attracted the cells to the 
material allowing them to produce the bone on its surface (osteoconduction) (21). 
Both processes resulted in implants satisfying osseointegration grade which was 
associated with the direct formation of bony tissue around the implant without the 
layer of fibrous tissue on the implant-bone surface (21).    
Up to date, there are several bone scaffolds which have been researched on 
horses (22-25). The features of bone scaffold used in this study are unique from 
other synthetic scaffolds (26). Most important is related to its hydrophilic structure 
which allows for implant swelling and filling non-uniform bone voids and 
incongruencies. Further advantage is related to its mechanical integrity. The 
combination of soft (PU) and hard components (nHA, DBP) gives it overall 
mechanical stability and stiffness greater than that of the individual components. 
The scaffold is being implanted into the defect in press-fits matter, and the flow of 
blood and cellular components leads to immediate hydration. Unique porosity, with 
pore size ranging between 50 and 800 μm and interconnected pore distribution, 
implant induces advanced and early neovascularization. is ideal for new bone 
formation based on the fact that the small pores facilitate early vascularization, and 
the larger ones facilitate larger blood vessel formation – resulting in rapid 
vascularization of the graft, which is responsible for fast and reliable new tissue 
formation (26). 
Horses may benefit from enhanced bone regeneration for several reasons. The 
most common include long and flat bone fractures (1-4), subchondral bone cysts 
(5-10), bone infections (11-14), and arthrodesis (46-51). Bone regeneration 
remains challenging in equids and the fractures have been associated with up to 
63% of fatal injuries in the racing industry (1-3). It is not uncommon that the 
fractures are open and comminuted (2,4,11-14). The current success rate of 
subchondral bone cyst treatment varies between 56-75% in the return to the 
previous level of performance (5-10). All the methods described in the literature 
are aimed at reducing the inflammation within the cyst as well as filling and 
decompressing the bone void (5-10). The rate of surgical site infection following 
the long bone fracture repair and arthrodesis has been reduced over the years and 
currently reported as 14% in one of the veterinary teaching hospitals (11-14). The 
chronic degenerative osteoarthritis often requires arthrodesis which success rate 
varies between 46-75% in the return to the previous level of performance (46-51). 
In all of these cases, the bone scaffolda used in this study could serve as a bone 
filler and enhance bone regeneration, potentially increasing the positive outcome 
of the treatment. Additionally, the implant may serve as a drug delivery device in 
infected tissue. 
This novel technology was tested in the equine splint-bone model, which has been 




bone partial ostectomy procedure is considered a safe method with minimal soft 
tissue disruption, which does not cause exostosis or sequestration formation (32). 
Furthermore, this procedure did not impair the perfusion and integrity of the distal 
fragment, which was most likely maintained from the periosteal and soft tissue 
vasculature (32). The horses tolerated the procedure well with the lack of 
noticeable pain, discomfort, or gait impairment. Because of the thick interosseous 
ligament between the fourth and third metacarpal bones, the osteotomies provide 
relatively stable, uncomplicated, and appositional bone healing models with the 
advantage of not requiring an internal fixator (32-38). Each horse can serve as its 
control because of multiple splint bones and therefore reducing the intra-individual 
healing variability (35). The limitation of this model is related to the fact that the 
fourth and second metacarpal bones are not fully weight-bearing bones as well as 
they do not contain a medullar cavity, therefore the entire healing process occurs 
from the periosteum. To the best of our knowledge, this is only one full-thickness 
long bone healing model described in horses. 
Conclusions  
The bone scaffold enhanced the splint bone regeneration after 60 days post 
implantation in the splint-bone healing model. The results were repeatable among 
the horses with relatively small inter-individual variation. Because of the unique 
design of this bone regenerative technology the implant can be further used as the 
drug delivery device. The future research direction therefore will include delivery 
of bioactive agents into the defect, such as commonly used platelet rich plasma 

























Table 5-1. Radiographical ostectomy gap filling scoring system.  
 








Ostectomy Gap Filling 
Score Ostectomy gap filling 
0 No interval change compared to immediate post-operative radiographs 
1 New bone filling <25% of ostectomy gap 
2 New bone filling 26-50% of ostectomy gap 
3 New bone filling 51-99% of ostectomy gap 
4 
Ostectomy gap completely filled and/or bridging callus present on at 
least 3 cortices 
Ostectomy Opacity 
Score Opacity of new bone  
0 No interval change compared to immediate post-operative radiographs 
1 New bone less opaque than normal cortex 




Table 5-3. CT ostectomy gap filling scoring system. 




Comparison of defect filling in scaffold and control 
No Defect filling in scaffold (%) Defect filling in control (%) 
1 62.31 39.01 
2 27.92 1.79 
3 81.59 31.68 
4 65.35 18.37 
5 99.92 88.58 
Mean 67.42 35.89 
St Dev ±26.68 ±32.69 
CT Ostectomy Gap Filling 
Score Ostectomy gap filling 
0 No evidence of new bone formation adjacent to graft or within 
osteotomy gap 
1 New bone filling <25% of ostectomy gap 
2 New bone filling 26-50% of ostectomy gap 
3 New bone filling 51-99% of ostectomy gap 







Figure 5-1. Bone scaffold.  
The figure presents two images, the image on the left side shows the 2 cm long 
bone scaffold and image on the right side shows bone scaffold placed within the 
defect created in the fourth metacarpal bone. (c) 2020 Photographs of bone filler 









Figure 5-2. Radiographic assessment of healing.  
The figure shows a representative sequence of radiographs taken throughout the 
study of the defect filled with the bone scaffold (A) and the control (B). The defects 
were created in the fourth metacarpal bones in same horse. Each sequence within 
the bone scaffold and control treatment group consist of four images which were 
recorded at 24h (starting from the left side), 14, 30 and 60 days after the 
implantation surgery. This figure shows gradual filling of defects containing bone 
scaffold with a new bone (A) as compared to the control, where the bone 







Figure 5-3. Ultrasonographic assessment of healing.  
The figure shows a representative sequence of ultrasonography images recorded 
throughout the study of defect filled with bone scaffold (A) and the control (B). Both 
defects were created in the same horse. Each sequence within bone scaffold and 
control treatment group consist of four images which were recorded at 24h (starting 
from top to bottom), 14, 30 and 60 days after the implantation surgery. The images 
show increased soft tissue swelling as well as fluid accumulation 14 days after 
implantation (second row of images from the top) that was similar in both treatment 
groups. The bone scaffold is being gradually covered with bone presented as the 
smooth hyperechogenic line (A). In the control defect, bone formation was minimal 




Figure 5-4. 3D CT reconstruction.  
The figure presents representative 3-D reconstructed computed tomography (CT) 
images of the fourth metacarpal bones in same horse. CT images were taken 60 
days after implantation and were used for illustration only. The image analysis was 
performed on 2D and slab reconstructed images. The defect filled with bone 
scaffold is labeled with a white circle. The CT confirmed significant bone formation 
within the defect containing bone scaffold as opposed to the control, where bone 








Figure 5-5. Scaffold and control histology. 
The figure shows histology at 10x magnification of a section harvested from the 
middle of defect filled with bone scaffold (A) and the control (B). The section 
harvested from bone scaffold shows bone formation adjacent to pores of bone 
scaffold. The tissue harvested from middle of the control defect represents 




Figure 5-6. Hyaline cartilage formation. 
The figure shows a histology image at 100x magnification of a section harvested 
from the middle of defect containing bone scaffold. The image shows a new bone 




Figure 5-7. Thermography graph.  
The graph shows changes in cutaneous temperature (°C) associated with local 
tissues adjacent to created defects. Temperature was measured with infrared 














Figure 5-8. Radiographic evaluation 2M after surgery.  
The comparison between treatment groups in the median values of radiographic 
scoring 60 days after implantation surgery 
Figure 5-9. Defect density 2M after surgery. 
The comparison between treatment groups in mean density the defect measured 





CT – Computed Tomography 
DBP – Decellularized Bone Particles 
DICOM – Digital Imaging and Communications  
DLPMO – Dorso-lateral Palmaro-medial Oblique 
HU – Hounsfield Units  
H&E - Hematoxylin and Eosin 
MC IV – fourth metacarpal bone 
NBF – Neutral Buffered Formalin 
nHA – nanophase Hydroxyapatite 
PACS – Picture Archival and Communication System  
PU – Polyurethane  



































a. NuCress™ bone scaffold, NuShores Biosciences LLC, AR 
b. Gentamicin sulfate,100mg/ml, VetOne®, Boise, ID   
c. Penicillin Procaine G injectable suspension, 300.000 units/ml, VetOne®, 
Boise, ID   
d. Firocoxib, Equioxx injectable, 20 mg/ml, Boehringer Ingelheim Animal 
Health USA Inc., Duluth, GA 
e. Xylazine hydrochloride, Xylamed, 100 mg/ml, VetOne®, Boise, ID    
f. Ketamine hydrochloride, Zetamine, 100 mg/ml, VetOne®, Boise, ID     
g. Midazolam, 5 mg/ml, Akorn, Ann Arbor, MI  
h. Isoflurane, 250 ml, VetOne®, Boise, ID      
i. PDS II - Polydioxanone #2-0 (3.0 metric) suture with CT-1 36 mm 1/2c 
taper needle, Ethicon, Guaynabo, Puerto Rico 
j. SurgiproTM – Polypropylene monofilament #0 (3.5 metric) suture with C-
17 39 mm 3/8 cutting needle, Covidien, Mansfield, MA 
k. Fluke VT04A Visual IR Thermometer, Fluke Corporation, Everett, WA  
l. NEXT Equine DR™, Sound Technologies, Carlsbad, CA 
m. Logic™ e Vet NextGEN®, Sound Technologies, Carlsbad, CA 
n. Philips® Brilliance-40™, Philips International B.V., Amsterdam, 
Netherlands 
o. Sectra® PACS™ IDS7, Sectra AB, Linkoeping, Sweden 
p. Microsoft Office Professional Plus 2016, Microsoft, Redmond, WA 
q. Fiji, ImageJ, National Institute of Mental Health, Bethesda, MD 
r. Neutral Buffered Formalin, Decalcifying solution protocol A, Fisher 
Scientific Co LLC, Hampton, NH 
s. IBM® SPSS Statistics™ v.25 Software, IBM, New York, NY 
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